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ABBREVIATIONS 
ASM               : activated sludge model 
bH,O2             : aerobic endogenous respiration rate of XH (d
-1) 
bSTO,O2            : aerobic respiration rate for XSTO (d
-1) 
COD             : chemical oxygen demand (mg.L-1) 
CS                   : substrate concentration (C mol.m
-3) 
CX                   : biomass concentration (C mol.m
-3) 
DO             : dissolved oxygen (mg O2.L
-1) 
DOTotal           : total dissolved oxygen (mg O2.L
-1) 
DOEndo            : dissolved oxygen for endogenous respiration (mg O2.L
-1) 
DOGro,PHA       : dissolved oxygen for growth on PHA (mg O2.L
-1) 
DOSto+Gro        : dissolved oxygen for growth and storage (mg O2.L
-1) 
fES                   : fraction of the soluble metabolic products 
fEX            : fraction of the particulate metabolic products 
fSI                    : production of SI in hydrolysis 
fXI                  : production of XI in endogenous respiration 
F/M             : food to microorganism ratio 
iSS,XI                : SS to COD ratio for XI (g SS.g COD
-1) 
iSS,XS                : SS to COD ratio for XS (g SS.g COD
-1) 
iSS,BM               : SS to COD ratio for biomass, XH, XA (g SS.g COD
-1) 
kH                    : hydrolysis rate constant (d
-1) 
kSTO            : maximum storage rate (d
-1) 
KALK               : half saturation constant for alkalinity for XH (g HCO3
-.m-3) 
KO2                 : half saturation constant for SNO2 (g O2.m
-3) 
KS                   : half saturation constant for substrate SS (g COD.m
-3) 
KSA  : half saturation constant for SSA (g COD.m
-3) 
KS1                  : half saturation constant for direct microbial growth (mg COD.L
-1) 
KS2             : half saturation constant for growth on stored product (mg COD.L
-1) 
KSTO             : half saturation constant for storage (g XPHB.gXH
-1) 
KX                   : hydrolysis saturation constant (g COD.g COD
-1) 
MBR               : membrane bioreactor 
MLVSS : volatile suspended solid (mg COD.L-1) 
mS                  : maintenance coefficient for growth on acetate (C mol.C mol
-1.h-1) 
mP                   : maintenance coefficient for growth on PHB (C mol.C mol
-1.h-1) 
mATP               : maintenance coefficient based on ATP (mol.C mol
-1.h-1) 
OUR             : oxygen uptake rate (mg OUR.L-1.h-1) 
PABA             : para-aminobenzoic acid 
PHA             : poly-β-hydroxylalkanoate 
PHB             : poly-β-hydroxybutyrate 
SALK                : alkalinity of the wastewater 
SI                     : inert soluble organic material (mg COD.L
-1) 
SNH                  : ammonium plus ammonia nitrogen (mg N.L
-1) 
SN2                   : dinitrogen (mg N.L
-1) 
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SNO                  : nitrite plus nitrate nitrogen (mg N.L
-1) 
So             : dissolved oxygen concentration (mg O2.L
-1) 
SP             : soluble microbial products (mg COD.L
-1) 
SS1 : readily biodegradable organic substrate (mg COD.L
-1) 
SSremoved : biodegradable organic substrate removed (mg COD.L
-1) 
SSA : biodegradable portion of antibiotic (mg COD.L
-1) 
SBR             : sequencing batch reactor 
SMX               : sulfamethoxazole 
SRT              : sludge retention time (d) 
SS                   : suspended solids (mg SS.L-1) 
TET                : tetracycline 
WWTP : wastewater treatment plant 
XA                   : autotrophic organisms (mg COD.L
-1) 
XH1             : heterotrophic biomass (mg COD.L
-1) 
XHA             : heterotrophic biomass active for antibiotic (mg COD.L
-1) 
XP             : particulate microbial products (mg COD.L
-1) 
XPHB             : stored internal PHB (mg COD.L
-1) 
XS                   : slowly biodegradable substrate (mg COD.L
-1)    
XSTO             : internal storage product (mg CODL
-1) 
XTS                 : total suspended solids (mg COD.L
-1) 
VSS                : volatile suspended solids (mg VSS L-1) 
YH             : heterotrophic yield coefficient for direct growth (g COD.g COD
-1) 
YH,O2               : aerobic yield of heterotrophic biomass (g COD.g COD
-1) 
YOBS             : observed yield (g COD.g COD
-1) 
YPX                 : yield of growth on the stored substrate (g COD.g COD
-1) 
max
PXY                : maximum yield of biomass on PHB (C mol.C mol
-1) 
YSP                 : yield of storage on substrate (g COD.g COD
-1) 
max
SPY               : maximum yield of PHB on acetate (C mol.C mol
-1) 
max
SXY               : maximum yield of biomass on acetate (C mol.C mol
-1) 
YSTO            : storage yield of PHB on acetate (g COD.g COD
-1) 
YSTO,O2           : aerobic yield of stored product per SS (g COD.g COD
-1) 
μ                     : specific growth rate (h-1) 
μH            : maximum growth rate of XH (d
-1) 
μHA            : maximum growth rate of XHA (d
-1) 
µSTO            : maximum growth rate of XH on XSTO (d
-1) 
δ                     : P/O ratio, ATP produced per NAHDH2 oxidized (mol.mol
−1) 
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FATE OF SULFAMETHOXAZOLE AND ITS INHIBITORY IMPACT ON 
THE BIODEGRADATION OF ACETATE UNDER AEROBIC CONDITION 
AT HIGH SLUDGE AGE 
SUMMARY 
In this study, acute and chronic effects and biodegradability of one of the major 
antibiotics, Sulfamethoxazole (SMX) was investigated. 
Activated sludge taken from a domestic watewater treatment plant (WWTP) was 
acclimated to acetate as a main carbon source and operated at a sludge age of 10 
days. The influent COD concentration of fill & draw reactor was kept as 400 mg 
COD/l.  
In acute inhibition experiments, biomass taken from the fill & draw reactor and 
having the same F/M ratio was used as well as fed acetate together with four 
different pulse feedings of 25 mg/L, 50 mg/L, 100 mg/L and 200 mg/L of SMX. In 
acute experiments, the observed antibiotic removal can be neglected. According to 
kinetic coefficients, maximum storage rate increased; however, endogenous decay 
rate decreased.  
In chronic inhibition experiments, biomass taken from the fill & draw reactor and 
having the same F/M ratio was used as well as fed acetate together with continuous 
feeding of 50 mg/L of SMX. In chronic studies, three different types of substrates 
were conducted in the experiments; mixed substrate (including acetate and 
antibiotic), only acetate and only antibiotic. Synthetic substrate and SMX 
acclimation were applied to the same quality activated sludge; the system was 
monitored by respirometric experiments and conventional parameters. On the fifth 
day of acclimation, it was observed that the storage process disappeared. After 
twenty days of operation, acclimation of the activated sludge to this mixture was 
seen and complete removal of SMX was obtained. Moreover, a higher maximum 
growth rate and a lower endogenous decay rate were monitored in the chronic 
experiments. 
In the study, relevant kinetic and stoichiometric coefficients were achieved using 
modified ASM3 pattern. 
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AEROBİK ORTAMDA YÜKSEK ÇAMUR YAŞINDA 
SÜLFAMETOKSAZOL’ÜN AKIBETİ VE ASETATIN BİYOLOJİK 
AYRIŞABİLİRLİĞİ ÜZERİNE İNHİBİSYON ETKİSİ 
ÖZET 
İlaç etken maddelerinin üretimi ve tüketimi son yıllarda oldukça artmıştır. Henüz 
çevre üzerindeki riskleri ve etkileri tam olarak bilinemediği için, bu maddelerin 
varlıkları ve giderimleri en önemli araştırma konularından biri olmuştur. Sık 
kullanılan bir ilaç türü olan antibiyotiklerin yıllık tüketimleri tüm dünyada yaklaşık 
500 ton’dur.  
Son yıllarda artan antibiyotik kullanımı hayatımızın her alanında kendini 
göstermektedir. Özellikle insan ve hayvan sağlığı, balık gibi sucul canlıların sağlığı 
ve gelişimi, tıbbi atıklar, endüstriyel aktiviteler, antibiyotik ve ilaç üreten endüstriler, 
gıda sektöründe besinlerin korunması, ev gereçleri, ürünler üzerine spreyleme, çiftlik 
hayvanlarının üretimi, balık çiftlikleri gibi alanlar antibiyotiklerin temel kaynaklarını 
oluşturmaktadır. Günümüzde geniş bir kullanım aralığına sahip olan antibiyotikler, 
insan ve hayvansal tıpta tedavi edici amaçlar için sıklıkla kullanılır. Bu nedenle, 
tedavi edici antibiyotiklerin kalıcı konsantrasyonları çevrede bulunur. 
Veterinerlikte hayvan sağlığı amacıyla kullanılan antibiyotikler tüketiciler tarafından 
kolay temin edilmesi ve maliyetinin ucuz olmasından dolayı yoğun bir şekilde 
kullanılmaktadır. Örneğin, kümeslerde ortaya çıkan bazı hastalıklarla mücadele 
amacı ile tavuk yemine antibiyotiklerin katıldığı bilinmektedir. Bu antibiyotikler, 
hayvanların eti veya yumurtası ile tüketiciye kadar ulaşabilmektedir. Bu tehlike 
nedeni ile antibiyotiklerin kullanılması kontrol altında tutulmalıdır. Ancak bilinçsiz 
ve gereksiz antibiyotik kullanımı sonucunda hem çevresel sorunlar hem de besin 
zinciri yoluyla canlılarda özellikle insanlarda sağlık problemleri meydana 
gelmektedir. 
Balık çiftliklerinde gerekli sağlığa uygunluk kurallarına uyulmamasından dolayı 
hastalıklar sıklıkla yaşanmakta ve büyük ekonomik kayıplar ortaya çıkmaktadır. 
Balıkların bakteriyel hastalıklarının tedavisinde en yaygın yöntem antibiyotik ve 
diğer bazı kimyasalların kullanılmasıdır. Yeme karıştırılarak balıklara verilen 
antibiyotiklerin tüketilmeyen kısmı suda çözünür veya zemine çöker. Atık yemle 
birlikte ortama geçen ilacın bir kısmı doğal ortamdaki balık ve kabuklular tarafından 
alınır ve bünyede birikerek yüksek konsantrasyonlar oluşturur. Antibiyotiklerin aşırı 
kullanımı standart antimikrobiyal uygulamalara karşı dirençli patojenlerin gelişimini 
de teşvik eder. Bunun sonucu olarak da besin zinciri yoluyla insanlar ve diğer 
canlılar sağlık sorunları yaşamaktadırlar. 
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Antibiyotikler mikroorganizmaların büyümesini durduran ya da öldüren biyolojik 
kaynaklı veya sentetik olarak elde edilen çok etkili biyoaktif maddelerdir. Etki 
tarzlarına ve etkiledikleri mikroorganizmalara göre çok sayıda antibiyotik 
bulunmaktadır. Mikroorganizmanın hücre duvarını bozmak, protein sentezini 
bozmak veya mikroorganizmanın ihtiyaç duyduğu maddeleri yok etmek 
antibiyotiklerin etkileri arasındadır. Antibiyotikler, doğada bakteriler veya mantarlar 
tarafından üretilir. Bu canlıların antibiyotik üretip bulundukları ortama salma 
nedenleri, diğer türlerle besin yarışı içinde olmalarıdır. Bu nedenle, bulundukları 
ortamda kendilerinden başka organizmaların yok olmalarını veya daha fazla 
büyümelerini engelleyen antibiyotik maddeleri üretirler. 
Antibiyotikler etki mekanizmalarına ve kimyasal yapılarına göre 
sınıflandırılmaktadır. Etki mekanizmalarına göre: Hücre duvarı sentezini 
engelleyenler, protein sentezini engelleyenler ve nükleik asitlere etki edenler 
şeklinde sıralanmaktadır. Antibiyotikler etki mekanizmalarına ve kimyasal yapılarına 
göre 9 ana başlık altında sınıflandırılmaktadır: β-Laktamlar (penisilin, sefalofosporin, 
monobaktam), Tetrasiklinler (oksitetrasiklin ve tetrasiklinler), Makrolid 
antibiyotikler (eritromisin), Aminoglikozidler (gentamisin, tobramisin, amikasin), 
Quinolonlar (siprofsaksin), Linkosamidler (klindamisin), Oksazolidler (linezolid), 
Sülfa antibiyotikler (sülfisosazol), Sasilik peptidler (vankomisin, polimiksinler). 
Veterinerlik alanında öncelikli olarak uygulanan antibiyotik sınıfları; tetrasiklin ve 
sulfamidlerdir. İnsan tedavisinde ise sentetik penisilinler, tetrasiklin ve makrolidler 
yaygın olarak kullanılır. 
Antibiyotikler konvansiyonel biyolojik arıtma proseslerine dirençli oldukları için, 
alıcı su kaynaklarına tam olarak arıtılamadan deşarj edilmektedirler. Bu nedenle, 
çıkış sularında ve alıcı ortamlarda birikmektedirler. Endüstride kullanılan prosesler 
ve kimyasallardan dolayı oluşan atıksular yoğun kirlilik içermekte ve toksik nitelikte 
olmaktadır. Bu maddeleri içeren ilaç endüstrisi atıksuların arıtımı için fizikokimyasal 
arıtıma ihtiyaç duyulmaktadır. Çünkü miktarları her geçen gün ekosistemde artan bu 
ilaç etken maddeleri, doğada antibiyotiğe dirençli patojen organizmaların artışına 
sebep olmakta ve bu durum halk sağlığı için büyük bir tehdit oluşturmaktadır. 
Aslında sorunların temelinde çevrenin korunmayıp yoğun olarak kirletilmesi ve 
doğal kaynakların bilinçsizce tüketilmesi gelmektedir. Özellikle doğal ortamların 
evsel, endüstriyel ve tarımsal faaliyetler sonuncunda yok olma aşamasına gelmesi 
insanları farklı arayışlara yöneltmiştir. Örneğin günümüzde akuatik yaşamın 
dengesinin bozulması ile balık çiftliklerinin hızla gelişip çoğalması ve bunun sonucu 
olarak da çevrenin göz ardı edilmesi yine çevre kirliliği olgusunu ortaya çıkarmıştır. 
Bu nedenle yapılan ya da yapılacak her faaliyette çevre koruma bilincinin ön planda 
olması gerekmektedir. 
Bu çalışmada, önemli antibiyotiklerden biri olan Sülfametoksazol (SM)’ün, aktif 
çamur sistemlerine olan akut ve kronik etkileri ve biyolojik arıtılabilirliği 
incelenmiştir. 
Bir evsel atıksu arıtma tesisinden alınan aktif çamur ana karbon kaynağı olarak 
asetata aklime edilerek 10 çamur yaşında çalıştırılmıştır. Doldur-boşalt çalıştırılan 
sistem kolay ayrışabilir organik olarak asetat ile beslenmiş ve giriş KOİ 
konsantrasyonu 400 mg KOİ/L olarak belirlenmiştir. Reaktör kararlı dengeye 
ulaşıncaya kadar ve sonrasında, konvansiyonel parametreler izlenerek kontrol altında 
tutulmuştur. 
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Akut inhibisyon deneylerinde, doldur-boşalt reaktörden alınan ve aynı F/M oranına 
sahip biyokütle kullanılmış ve asetat ile birlikte SM’ün 25 mg/L, 50 mg/L, 100 mg/L 
ve 200 mg/L’lik dört farklı konsantrasyonu anlık olarak beslenmiştir. Akut 
inhibisyon deneylerinde gözlenen antibiyotik giderimi ihmal edilebilir düzeydedir. 
Kinetik katsayılara bakıldığında, maksimum depolama hızının azaldığı; fakat içsel 
solunum hızının arttığı görülmüştür. 
Kronik inhibisyon deneylerinde, doldur-boşalt reaktörden alınan ve aynı F/M oranına 
sahip biyokütle kullanılmış ve asetat ile birlikte SM’ün 50 mg/L’lik konsantrasyonu 
sürekli olarak beslenmiştir. Kronik çalışmalarda üç farklı substrat tipi uygulanmıştır: 
karışık substrat (antibiyotik ile asetat içerir), yalnızca asetat ve yalnızca antibiyotik. 
Aynı nitelikteki aktif çamura sentetik atıksu ile sülfametoksazol aklimasyonu birlikte 
uygulanmış; respirometrik çalışmalar ve konvansiyonel parametrelerle sistem 
izlenmiştir. İlk 5 günlük aklimasyon sürecinde, depolama işleminin ortadan kalktığı 
görülmüştür. 20 günlük işletim periyodu sonunda aktif çamurun bu karışıma alıştığı 
gözlenmiş ve SM’ün tamamen giderildiği görülmüştür.  
Çalışmadaki ilgili stokiyometrik ve kinetik katsayılar, modifiye edilmiş ASM3 
modeli kullanılarak elde edilmiştir. 
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1 INTRODUCTION 
1.1 Purpose of Thesis 
Antibiotics are commonly used for either prevention or treatment of diseases caused 
by microorganisms. Since antibiotics cannot totally be excluded from the 
environment, it is important to obtain best treatment techniques for elimination of 
their severe effects on the aquatic and terrestrial ecosystems.  
In order to investigate the elimination mechanism of antibiotic substances in 
activated sludge systems and their effects on these systems, a model substance was 
chosen in this study. This substance, which is among the abundantly used antibiotic 
compounds in the world and in Turkey, was chosen to represent one of the major 
groups of antibiotics. The antibiotic SMX was chosen to represent Sulfonamide 
group of antibiotics. 
Main objectives of the study carried out with the chosen antibiotic can be given as 
follows: 
 Determination of inhibition effects of SMX on the aerobic activated sludge 
culture under both acute and chronic conditions 
 Observation of the effects of the inhibiting substance on the activity of the 
microbial culture 
 Investigation of the biodegradability characteristics of SMX by the aerobic 
activated sludge culture in SBR 
 Identification of the storage ability of microorganisms when readily 
biodegradable substrate (acetate) and/or SMX was subjected 
As a last step of the thesis, the biochemical processes occurring under inhibiting and 
non-inhibiting conditions were modelled with the aid of the results obtained from 
experimental studies. Using the data obtained from analyzes, optimum model 
parameters were developed for optimum treatment of antibiotic containing 
wastewaters. 
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1.2 Scope of Thesis 
The fate of antibiotics in wastewater treatment systems is of particular concern, 
because they are likely to exert adverse effects on treatment process efficiency and 
by-pass treatment systems. This study focused on the acute and chronic effects of a 
major antibiotic, SMX, on mixed microbial culture. For this purpose, two SBRs were 
operated at steady state conditions with a sludge retention time (SRT) of 10 d. One of 
them was “control reactor” fed with the acetate as a sole carbon source for acute 
experiments and the other one was operated at the same conditions except for the 
carbon source. Both reactors had the same total volume of 10 l. In the second reactor, 
namely “antibiotic reactor”, biomass was acclimated to selected antibiotic, for 
chronic experiments. During the acclimation studies, SS and VSS analyses were 
made and also, samples were collected from these reactors, regularly. The collected 
samples including soluble COD, SMX and PHA were analyzed for the microbial 
compositions, treatment efficiencies and substrate storage capacities. The acute and 
chronic effects of SMX on the activated sludge diversity were investigated by 
oxygen uptake rate (OUR) measurements. 
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2 LITERATURE REVIEW 
2.1 Antibiotics 
2.1.1  Background 
Pharmaceuticals in the environment first became a focus of scientific interest and 
public awareness in the 1970s. Some investigations to prove the existence of 
pharmaceuticalss in the effluent of wastewater treatment plants (WWTPs) were 
carried out in the mid 1980s, mainly in Great Britain. These reports triggered more 
detailed investigations into the occurrence, fate and effects of pharmaceuticals in the 
environment in Europe, the USA and Canada. Meanwhile, a high awareness about 
the effects of pharmaceuticals in the environment has grown since the mid 1990s all 
over the world [1]. 
Antibiotics are among the most important groups of pharmaceuticals that are 
persistent to biodegradation and have the tendency to accumulate in the environment 
[1,2]. They are widely used in human and veterinary medicine as well as the 
aquaculture for preventing and/or treating microbial infections, while they are used 
to promote growth of animals in livestock farming. Some antibiotics are also used in 
growing fruit and in bee keeping [1]. 
Human beings have used antibiotics since the beginning of the century as this type of 
synthesized chemicals play a very positive effect in human society in fighting against 
various diseases [3]. Many antibiotics can be changed structurally by 
microorganisms in the gut or by enzymes in the bodies of humans and animals, 
respectively. While some of these antibiotics are largely metabolized before they are 
excreted, others can only be moderately or poorly metabolized [1]. 
However, because of their wide application, various antibiotics have been detected in 
all environmental media, such as WWTP effluents, surface water, seawater, 
groundwater, soils, and sediments. This wide presence of antibiotics in the 
environment has brought public and scientific concerns. For example, some of the 
antibiotics have harmful effects on human metabolism or organisms and thus, disrupt 
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the balance of the ecological system [3]. The release of the antibiotics to aquatic 
environment is very important since it may contaminate raw, treated, recycled, 
irrigation and recreation water. This contamination can cause to irreversible negative 
effects on ecosystem bacteria such as toxicity and inhibition [4]. 
For the environmental engineering point of view, the ecological system can damage 
irreversibly as microorganisms may develop drug-resistance to these antibiotics after 
long-term contact [3]. Researches about persistence and long-term adverse effects of 
antibiotics on the environment have been raised after the reports on the undesirable 
ecological and potentially human health effects of antibiotics even if they present in a 
very low concentrations. The concentrations in WWTP effluents have been shown to 
lie in the range of ng/l to µg/l, and in surface waters in ng/l for different countries. 
Antibiotic compounds, which are mostly polar, are generally present at the parts-per-
trillion or low parts-per-billion range [1,5,6].  
2.1.2 Sources of antibiotics 
Possible irresponsible consumption of antibiotics, which leads to resistant pathogenic 
microorganisms living in the aquatic environment and soil, causes a great deal of 
concern regarding the fate of antibacterial compounds in relevant water treatment 
processes [7]. An important source of pharmaceutical contaminantion is through land 
application of livestock manure, which contains antibiotics due to the usage of them 
either as growth promoters or as therapeutic agents to fertilize crops. Furthermore, 
after heavy rain, veterinary antibiotics may reach surface water due to run-off from 
the soil, and eventually reach the drinking water supply [1,5]. The presence of 
antibiotics in the aquatic environment is of particular concern because of fears that 
they may stimulate dissemination of antibacterial resistance among native bacterial 
populations. Even though a causal link between chronic exposure to sub-therapeutic 
concentrations of antibiotics and induction of antibacterial resistance has yet to be 
proven, singly and multiply antibacterial resistant bacteria have been detected in 
municipal wastewater effluents, sewage-affected surface water systems, and even in 
drinking water [8]. Pathways of the antibiotics and their metabolites in the 
environment are schematically indicated in Figure  2.1 [1]. 
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Figure  2.1 : Pathways of antibiotics and their metabolites in the environment. 
Antibiotics are a diverse group of chemicals that can be divided into subgroups such 
as β-lactams, quinolones, tetracyclines, macrolides, sulfonamides etc. [1]. SMX is an 
important member of the synthetic sulfonamide antibacterials or sulfa drugs, and 
often prescribed in tandem with antibacterial agent trimethoprim, which does not 
belong to any specific class as a major first-line clinical option for treatment of 
various bacterial infections. Sulfonamides have been used extensively for many years 
in human and veterinary medicines to treat diseases and infections such as urinary 
tract infections, bronchitis, sinusitis, toxoplasmosis or ear infections, and in feed 
additives to promote livestock growth and weight gain of food animals [3,5,7]. SMX 
is a structural analog of para-aminobenzoic acid (PABA) and inhibits bacterial 
synthesis of dihydrofolic acid, which is important for DNA production, by competing 
with PABA [9,10].  
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As summarized in Table  2.1, sulfonamide compounds contain two moieties 
connected to both sides of the characteristic sulfonamide linkage. Sulfonamides 
exhibit two acid dissociation constants (pKa1 & pKa2); one involving protonation of 
the aniline N, and the other corresponding to deprotonation of the sulfonamide NH, 
as shown in Figure  2.2 [7]. 
Table  2.1 : Sulfamethoxazole and associated substructure model compounds [7]. 
Compound Structure Mol. Weight pKa 
Sulfamethoxazole 
(SMX) 
 
 
 
253.28 
pKa1=1.7, 
pKa2=5.6 
3,5-dimethylisoxazole 
(DMI)  
97.12 Not Available 
4-aminophenyl methyl 
sulfone (APMS)  
171.22 pKa1=1.5 
4-methyl-N-(5-methyl-
isoxazol-3-yl)-
benzenesulfonamide 
(MMIB) 
  252.29 Not Available 
 
 
Figure  2.2 : Speciation of sulfamethoxazole. 
Because of their wide application, various antibiotics have been detected in all 
environmental media, such as sewage treatment plant effluents, surface water, 
seawater, groundwater, soils and sediments [11,12]. The removal rate of SMX in 
wastewater treatment facilities is lower as compared to other antibiotics including 
fluoroquinolone and macrolide groups [13]. In addition, SMX showed lower 
adsorption to sludge, solids, and sediments in comparison to other antibiotics [14-
16]. Therefore, a large quantity of SMX will remain in water and could be available 
to organisms and has higher risks to the environment as compared with other 
antibiotics. In this context, SMX has been detected in raw influents of WWTPs at 
concentration level of 118 ng/l in Southeast China, 580 ng/l in Spain, and 520 ng/l in 
the USA [13,17,18]. Among the target analytes measured, SMX in particular has 
been repeatedly detected at concentrations of 70-150 ng/l in surface waters and 200-
2000 ng/l in secondary wastewater effluents [19-23]. 
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However, certain point sources, such as waste streams and effluents generated by 
hospitals, may have higher antibiotic concentrations, in order of between 10 to 600 
mg/l [24,25].  
Another important class of antibiotic among the Tetracyclines group, which are 
broad-spectrum bactreiostatic antibiotics, is the Tetracycline (TET). This antibiotic is 
important since it can cause adverse effects on protein biosynthesis by reversibly 
binding to the 30S ribosomal subunit and inhibiting translation [26,27]. 
Investigations have shown that TET is present in liquid manure at concentrations up 
to 20 mg/l, respectively. Moreover, the authors conclude that TET enters the soil in 
significant concentrations in liquid manure, builds persistent residues and 
accumulates in the soil [1]. 
The release of high levels of antibiotics is problematic in at least three ways. First of 
all, the antibiotics may impair the general treatment efficiency of effluent by killing 
microorganisms or preventing them from growing. Secondly, the antibiotics are very 
likely to affect the local environment, including microbial ecosystems. Thirdly, and 
perhaps most importantly, the release raises serious concerns about an accelerated 
rate of microbial resistance development [1]. 
2.1.3 Fate of antibiotics 
Over the past decade, a great amount of interest has arisen regarding the occurrence 
and fate of trace organic contaminants, many of which are ubiquitous in municipal 
WWTPs. For this reason, many studies about the presence of antibiotics in the 
environment have focused on transformation and fate of them as they are released, 
move through wastewater treatment processes, are discharged and transported 
through surface waters or ground waters, and ultimately result in exposure to human 
and aquatic life [5,6,9,27].  
Very large numbers of antibiotics used in human and veterinary medicine are 
industrially produced and commercially used, but they are not required to undergo 
the extensive level of testing for possible environmental impact. They and their 
metabolites have therefore been subject to many years of unrestricted emission to the 
environment, directly or via WWTP effluents or sludge [1]. Disposal of antibiotics 
through manufacturing and packaging facilities in the environment means that many 
different substances in varied concentrations, products and modes of action have to 
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be considered [5,28]. In this context, their identification and quantification in the 
aquatic environment has become an issue in order to develop the analytical 
techniques needed to quantify their occurrence in effluents, but also to assess their 
chemical properties, their biodegradability potential, etc. [1,29].  
Analysis of the antibiotics in the environment nowadays is mostly done by LC-
MS/MS, some by GC/MS-MS. These medical substances have been measured in the 
effluent from hospitals and domestic WWTPs, as well as in surface waters, 
groundwaters and drinking waters. Antibiotics have also been detected in the 
leachate from landfills [1]. 
The fate of the antibiotics can be divided into three categories; transport, 
sequestration, and degradation. The predominant fate processes most likely to 
transform or mineralize the antibiotics, and more permanently remove them from the 
aquatic environment, include photolysis, hydrolysis, and biodegradation. Antibiotics 
may also be transferred without degradation and storage, at least temporarily, in 
other matrices or compartments through processes such as sorption and deposition of 
particles [1,5]. 
2.1.4 Antibiotics in wastewaters 
Some pharmaceutical substances have been detected in sewage, the effluents of 
WWTPs, surface waters, manures and soil since the 1980s [1]. Municipal 
wastewaters contain many organic compounds, among them, active ingredients of 
pharmaceuticals and personal care products, which are used in large quantities 
throughout the world. Most of these compounds come either from domestic sewage 
or from hospital or industrial discharges and enter municipal WWTPs. Generally, 
antibiotics are absorbed by the organism after intake and are subject to metabolic 
reactions. However, a significant fraction of the original substances leave human or 
animal organisms unmetabolized via urine or feces being therefore emitted into raw 
sewage, sewage sludge or manure [29]. 
Modern WWTPs can effectively accomplish carbon and nitrogen removal, as well as 
microbial pollution control. However, urban WWTPs normally receive streams that 
contain a lot of different trace polluting compounds (synthetic and natural), for which 
conventional treatment technologies have not been specifically designed [29]. In this 
context, WWTPs can be considered as an important point source for antibiotic 
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contamination of surface waters. Consequently, significant fractions of the antibiotics 
are discharged with the final effluent of the WWTPs into the aquatic environment. 
Besides, these substances can also imply an important pollution source for the soil if 
primary and secondary sludge to which they are adsorbed are spread on land [5,30]. 
It is often assumed that hospitals are the most important source for input of the 
antibiotics and resistant bacteria into municipal wastewater. Concentrations of 
antibiotics in municipal sewage and in WWTPs are much lower than in hospital 
effluent. However, taking into consideration that hospital effluents contribute to less 
than 1% of the total amount of municipal sewage, it is plausible that hospitals are not 
the main source for resistant bacteria in municipal sewage. Because of the use of 
antibiotics in houses, it is probably the general community that is responsible for the 
main input of resistant bacteria into WWTPs [1]. 
2.2 Removal Mechanisms of Antibiotics 
Although WWTPs are designed to remove pathogens and nutrients from sewage, 
antibiotics and other emerging chemicals found in wastewater can be incidentally 
removed, but the elimination is variable. Since, chemicals are moderated in 
wastewater treatment either through dilution, oxidation by disinfectants, biological 
degradation or sorption to the solid materials and are settled out of the system [5].  
Researchers have focused on the removal of antibiotics by biodegradation in many 
different systems, including WWTPs, membrane bioreactors (MBRs), sequencing 
batch reactors (SBRs), sand columns, and constructed wetlands [28]. On the other 
hand, despite the wide consortium of microorganisms present in the activated sludge, 
it is unlikely that antibiotics present as micro contaminants in wastewater which can 
be effectively removed by biodegradation alone. First, the relatively low 
concentration of antibiotics from other pollutants may be insufficient to induce 
enzymes that are capable of degrading antibiotics. Second, many of these compounds 
are bioactive, which can inhibit growth or metabolism of microorganisms. Thus, it is 
unlikely that antibiotics will be favourable energy or carbon sources of 
microorganisms. Third, the degree of biodegradation will depend on the nature of 
each compound and the operating conditions, such as SRT or the combination of 
anoxic/aerobic steps that could improve the efficiency [1,5].  
 
10
Wastewater treatment plays an important role in removing contaminants from 
reclaimed water. However, large variability in removal efficiency was reported for 
some antibiotics, implying that factors other than compound-specific properties 
affect removal efficiency [31].  
The biological wastewater treatment technique is regarded as one of the most 
promising treatment approaches for removal of contaminants from wastewater 
because of its affordable cost and high efficiency [30]. The primary pollutant 
removal mechanisms in conventional wastewater treatment processes are adsorption 
onto suspended solids and biodegradation, which mainly takes place in the aerobic 
treatment. Therefore, it is reasonable to assume that key component in biological 
WWTPs responsible for the removal of antimicrobial pollutants in the aeration basin 
containing the microorganisms. Biodegradation and sorption also could take place in 
other unit processes, such as primary settling, but removal efficiencies are difficult to 
control at this stage [5]. Their removal efficiencies are influenced, apart from the 
chemical properties of specific compounds, by microbial activity and environmental 
conditions [29]. 
Sorption is an important elimination pathway, which depends on the extent of neutral 
and ionic species present and the characteristics of the target particles. It may have an 
impact on the spread and bioavailability of antibiotics in the environment and their 
removal during wastewater treatment. The ability to estimate the sorption of an 
antibiotic to solids in various media is critical to understand. The antibiotic TET is 
known to have a tendency to bind to soil particles or to form complexes with double 
cations, such as calcium or magnesium. More than 50% of TET can be eliminated by 
sorption to sewage sludge [1,8,27]. 
Another kind of abiotic elimination of substances is hydrolysis. For example, 
hydrolysis rates for TET increase as pH deviates from 7 and as temperature 
increases. However, sulfonamides are stable against hydrolysis [1]. 
Removal of SMX is observed in biological treatment systems with a long hydraulic 
retention time, such as extended aeration, where there is an absence of a readily 
biodegradable substrate [32]. The removal efficiency for SMX during wastewater 
treatment in full scale plants is ranged from no removal to greater than 98% removal. 
In a lab scale SBR, cometabolism of SMX with acetate is observed and it is found 
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that microorganisms may use the degraded antibiotic as a nitrogen source [9]. The 
overall removal efficiency of the WWTP in NW Spain is around 60% for SMX [29]. 
Some antibiotics, such as quinolones, tetracyclines are sensitive to light. If a 
substance is sensitive towards light, photodegradation may be of major significance 
in the elimination process. Photodecomposition takes place mainly in surface water 
due to the presence of light. Since the effectiveness of the processes depends on light 
intensity and frequency, and the latter relates to the absorption spectrum of a 
compound, phototransformation may not occur when the compounds are present in 
turbid water or if the creek, river or lake is shadowed by trees [1]. 
Respirometry, which is the measurement and interpretation of the biological oxygen 
consumption rate under well defined experimental conditions, has been commonly 
used to determine whether a certain compound is toxic or inhibitor or not to a 
biomass content of a WWTP [33,34]. The toxicity of a certain compound can be 
assessed by evaluating the OUR profile obtained from a pulse feeding of substrate to 
endogenous biomass and then comparing the OUR profiles obtained from the pulse 
feeding consists of the substrate and a toxic or inhibitor compound. However, using 
this method with biodegradable compounds leads to some difficulties because the 
toxic consumption implies oxygen consumption as well. Then, respirograms obtained 
adding the substrate with the possible toxic or inhibitor cannot be reliably compared 
to the ones obtained adding only substrate. Therefore, it can be really complex to 
distinguish between the oxygen consumption due to substrate and the oxygen 
consumption due to the inhibitor, especially when biodegradability rates of inhibitor 
and substrate are similar [34]. 
2.3 Enzymatic Effects of Antibiotics on WWTP 
Enzymes are very complex and specific catalytic molecules produced by 
microorganisms, capable of accelerating reaction rate by lowering the activation 
energy of the biochemical reaction they catalyse [35,36]. In biochemical reactions, 
the biodegradable wastewater components act as substrates to form an enzyme-
substrate complex that is generated by the attachment of substrate on the active site 
of the specific enzyme molecule. When the biochemical reaction is completed, the 
active site is liberated and returns to its cyclic function to receive another substrate 
molecule. Sometimes, enzymatic functions may be retarded or even stopped by 
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inhibitors which may either compete for or simply block the active sites. A number 
of pollutants present in wastewater such as nonbiodegradable organics, antibiotics, 
etc. may exert significant inhibitory action upon biological treatment processes [36].  
The mechanism of enzyme kinetics is based on the attachment of the substrate to the 
enzyme to yield a product. It provides a practical tool to mathematically explain the 
behavior of microbial cultures under inhibitory effects. The general equation for 
enzyme-substrate reactions as applicable to biological treatment systems (2.1) 
[35,36]: 
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E S ES E P                                         (2.1) 
where S, E, ES and P represent concentrations of substrate, free enzyme, enzyme-
substrate complex and product, respectively. Since the last step (defined by k3) is 
considered the controlling step or slower step, the attachment of the substrate to the 
enzyme is regarded in equilibrium, which is defined by k1 and k2. On the basis of 
these reactions, the rate of formation of the enzyme-substrate complex is expressed 
as (2.2): 
    1 2 3. ( )
dES
k E S k k ES
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                                          (2.2) 
with the simplifying assumption that the reactions proceed under equilibrium 
concentrations of the enzyme-substrate complex, the above equation is found as 
(2.3): 
    2 3
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                                                       (2.3) 
A mass balance on enzyme species yields (2.4): 
    0E E ES                                                               (2.4) 
where E0 is the initial free-enzyme concentration. If the value of E in Equation (2.4) 
is substituted in Equation (2.3), the resulting expression is: 
    0
S
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
                                                         (2.5) 
where KS is a combination of the kinetic constants for both step (2.6)s: 
 
13
    2 3
1
S
k k
K
k

                                                              (2.6) 
Since the activated complex decomposition is assumed as a slow process, k3 is small 
and therefore KS approximately defines the equilibrium or affinity coefficient [35]. 
On the other hand, the rate of substrate utilization is defined as (2.7): 
     1 2.
dS
k S E k ES
dt
                                                    (2.7) 
or 
    3
dS
k ES
dt
                                                               (2.8) 
Substituting the value of ES in Equation (2.5) into the Equation (2.8) yields (2.9): 
    M
S
dS S
V
dt K S
 

                                                    (2.9) 
where 3 0MV k E , a constant which defines the maximum rate of substrate utilization. 
An analogy between the above Michaelis-Menten equation and the Monod equation 
may be established with the assumption that the total enzyme concentration is 
proportional to the active biomass concentration in the reactor (2.10) [36]: 
    3 0M mV k E k X                                                     (2.10) 
The capacity for yielding a product, in the mechanism described in Equation (2.1), 
may be lost when there is an interfering substance interacting either with the same 
specific site of the enzyme – competitive inhibition. Another possibility is the 
interaction of the inhibitor with the activated complex – uncompetitive inhibition 
[35].  
2.4 Inhibition Effects of Antibiotics on WWTPs 
Since biological processes deal with living organisms, they are subject to upset by 
inhibitory or toxic agents. Inhibition is caused either by chemical or physical agents, 
such as pH, temperature, oxidation-reduction potential of the medium, etc. On the 
other hand, many substances that are present in wastewater exert inhibitory effects on 
the microorganisms in a WWTP. In the context of biological wastewater treatment, 
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inhibition is defined as impairment of the enzymatic system of the living cell or 
direct damage to the cell structure, resulting in the slowing down of the cell activity 
[35]. 
pH and temperature, the two most common variations within a process, can lead to 
severe inhibitory conditions since all living systems are rather limited in their 
operating range. The effect of these parameters or any other, on the microbial activity 
is non-monotonous in nature. This means there are values for these parameters where 
the activity is at its optimum. Outside these values, the system does not perform at its 
peak that is interpreted as inhibition. On the other hand, the presence of inhibitory 
substances should be taken into account in terms of their adverse effects on the 
biomass activity. One clear manifestation of the activity is the oxygen consumption 
rate in aerobic processes, which is recognized as respirometric rate. OUR profiles are 
comprehended for the evaluation of substrate removal mechanisms. Respirometric 
test for inhibitory environments or for a specific substance is based on the 
measurement of a standard decrement in respirometric rate: the difference in 
respiration relative to a non-inhibitory situation [35]. 
When a microorganism is subject to ever increasing concentrations of an inhibitory 
substance, its activity, which is measured by the substance degradation rate or 
growth rate, diminishes until it reaches a point when all activity ceases. This point, 
i.e. the concentration level of the inhibitor, depends on the previous exposure of the 
microorganism to the same compound. The cell has the ability for adaptation, as it is 
capable of developing its enzymatic machinery to a point at which the inhibitor can 
also be used as substrate; perhaps at the expense of cell energy reserves. As the 
adaptation progresses, the microorganism is capable of tolerating higher 
concentrations and still perform close to the non-inhibiting condition. Obviously, 
time is important when dealing with exposure; there are short-term and long-term 
exposures, and the latter is useful for adaptation, especially if the concentration is 
low at the beginning [35].  
Today, wastewater management is greatly complicated by the presence of 
biologically resistant substances such as heavy metals, antibiotics, etc. commonly 
called inhibitors. This becomes critically important in developing local pretreatment 
programs. In these programs, the effect of an incompatible pollutant on a treatment 
plant receiving both domestic and industrial wastewater from a community must be 
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evaluated from three perspectives: impact on the treatment plant, impact on the 
receiving water, and impact on sludge. The limit for that pollutant can then be set to 
ensure that all objectives are met. The most stringent of the three will determine the 
influent limit to be used for the pollutant [36]. 
The most important part of this management scheme is to derive a numerical value 
that would give an appropriate indication of the inhibitory effect. The expected 
indication is not only a certain inhibitory response, but it should also reflect a safety 
factor. In practice, the common way to reach this numerical limit is through 
empirical observations and evaluations. To calculate a discharge limit that will 
prevent inhibition of an activated sludge process, the traditional way is to check if an 
inhibition or upset condition exists (e.g., settling characteristics, level of mixed liquor 
suspended solids, etc.). If an upset condition is noted, the concentration of the 
pollutants most likely to cause the irregularity are determined and compared with the 
likely inhibitory threshold concentrations of the same pollutants [36]. 
A major achievement in trying to understand and utilize the concept of inhibition 
would be to describe it physically and mathematically, in terms of simple and 
meaningful parameters, and incorporate this model into general mass balance 
expressions of the activated sludge process. This approach inevitably defines a set of 
kinetic constants or operational parameters specifically related to the inhibition 
mechanism, and its merit chiefly relies upon experimental methods to quantify these 
constants and parameters. In other words, this approach is useful only if it is used in 
conjunction with experiments that would yield accurate and uniformly consistent 
results for its kinetic constants [36]. 
The mathematical models of the complex interactions of inhibitors with the microbial 
community in activated sludge systems are of practical significance if they can be 
evaluated within the framework of substrate removal kinetics. This approach is 
adopted in a number of studies defining the effect of inhibitors in terms of enzyme-
catalyzed reactions [36]. 
There are three classic forms of inhibition including competitive, noncompetitive, 
and uncompetitive inhibition. In addition, the mixed case exists, sharing 
characteristics of competitive and uncompetitive inhibitors. Substrate inhibition is 
also reported in literature as a noncompetitive type of inhibition [35,36]. 
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2.4.1 Competitive inhibition 
Competitive inhibition defines the case where substrate, S, and inhibitor, I, compete 
for the same enzymatic site; the inhibitor can take the place of the substrate to form 
an enzyme inhibitor complex (EI), which cannot undergo further reactions with the  
substrate. When incorporated into the basic enzyme kinetics described by Equation 
(2.1), competitive inhibition involves the following additional reaction (2.11) [36]: 
    E I EI                                                             (2.11) 
Since the inhibitor (I) occupies the same site as the substrate, the result is a modified 
affinity, i.e. the apparent decrease in the forward reaction of the equilibrium in 
Equation (2.1). This concept defines a dissociation constant, KI (2.12) [35,36]: 
    
.
I
E I
K
EI
                                                                 (2.12) 
The mass balance for enzyme components yields (2.13): 
    0ES E E EI                                                      (2.13) 
Substitution of the value of EI in Equation (2.12) and the value of E in Equation (2.3) 
into the above mass balance permit to define ES in terms of the initial free-enzyme 
concentration, E0 (2.14):  
    0
1S
I
E S
ES
I
K S
K

 
  
 
                                            (2.14) 
This changes the basic rate Equation (2.8) into the following form (2.15): 
    
.
1S
I
dS S X
dt Y I
K S
K

 
 
  
 

                                     (2.15) 
It is noted that Equaiton (2.15) differs from the Monod expression only in term 
1+1/KI which affects the value of Ks, so that an “apparent” K's is measured for 
competitive inhibition (2.16) [36]: 
    ' 1S S
I
I
K K
K
 
  
 
                                             (2.16) 
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A Lineweaver-Burk plot for this case is presented in Figure  2.3 and shows effects of 
competitive inhibition on kinetic parameters [35]. 
 
Figure  2.3 : Competitive inhibition. 
2.4.2 Noncompetitive inhibition 
In noncompetitive inhibition, the inhibitor does not compete for the active site; once 
attached somewhere else on the enzyme, it changes its composition and prevents the 
product from being formed. In this case, the inhibition reaction cannot be reversed by 
raising the substrate concentration. The substrate is then unable to prevent the 
combination of the inhibitor with the enzyme. The magnitude of inhibition will 
accordingly depend on I and K1, and it will not be influenced by S or ES. The 
mathematical interpretation of the preceding statement gives in Equation (2.17) 
[35,36]: 
    0 0'E E EI                                                           (2.17) 
This expression implies that the inhibitor blocks a portion of the initially present 
enzyme concentration, Eo, so that only Eo is practically available for substrate. Then, 
Equation  (2.18):  
    0
'.
I
E I
K
EI
                                                              (2.18) 
and combining Equations (2.17) and (2.18), EI is defined (2.19): 
    0
I
E I
EI
K I


                                                           (2.19) 
For the substrate-enzyme interaction the following mass balance applies (2.20): 
    0 0'E E EI E ES                                              (2.20) 
Using Equations (2.3) and (2.19), this mass balance equation can be arranged to 
define ES (2.21): 
1
ES
1
S
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0
I
I
S
K
E S
I K
ES
K S
 
  

                                               (2.21) 
Since there is no competition, the affinity of the substrate is not modified, and as a 
consequence, KS remains constant; however, Eo decreases in the presence of I. The 
corresponding rate expression for substrate then becomes (2.22): 
    I
I S
KdS SX
dt Y I K K S
  
     

                                    (2.22) 
It is clear from Equation (2.22) that system will behave as if it contained less enzyme 
in the presence of a noncompetitive inhibitor, and consequently the maximum 
growth rate, μ

will be apparently reduced to a lower level (2.23) [35,36]: 
    ' I
I
K
I K
 
 
   
 
                                                     (2.23) 
The slope of Lineweaver-Burk plot (Figure  2.4) increases with rising inhibitor 
concentration in this case [35]. 
 
Figure  2.4 : Noncompetitive inhibition. 
2.4.3 Uncompetitive inhibition 
In this type of inhibition, the inhibitor attaches to the active complex formed by the 
substrate, blocking the product formation. Both parameters are modified by the 
presence of the inhibitor, KS and Eo decrease. Then, the kinetic expression takes the 
following form (2.24): 
    0
1S
I
E S
ES
I
K S
K

 
  
 
                                            (2.24) 
The Lineweaver-Burk representation for this case is given in Figure  2.5 [35]. 
1
ES
1
S
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Figure  2.5 : Uncompetitive Inhibition. 
2.4.4 Mixed inhibition 
In this case, both parameters change Eo decreases and KS increases, while the overall 
affinity decreases. This model is written as (2.25): 
    0
'1 1S
I I
E S
ES
I I
K S
K K

   
     
   
                             (2.25) 
The Lineweaver-Burk representation of mixed model is shown in Figure  2.6, which 
is similar to the competitive inhibition model [35]. 
1
S
 
Figure  2.6 : Mixed inhibition. 
2.4.5 Substrate inhibition 
Substrate inhibition is described on the basis of the assumption that some substrates 
have the ability to bind with the enzyme-substrate complex as well as with the free 
enzyme at high concentrations. This leads to the formation of a substrate-enzyme-
substrate complex (SES) which cannot undergo further reaction and does not yield 
the product (P). This can be seen as a special case of uncompetitive inhibition, 
whereby the same substrate inactivates the enzyme. The following reactions may be 
used to represent this mechanism (2.26) [35,36]: 
     
ISK
ES S SES                                                  (2.26) 
where 
1
S
1
ES
1
ES  
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.
IS
ES S
K
SES
                                                             (2.27) 
By using the approach previously outlined, the following rate expression can be 
developed (2.28): 
    
2IS
S
IS
S
S
K S
K
 
 
  
 

                                         (2.28) 
where  is the specific growth rate under substrate inhibition [36]. 
This expression is generally known as Haldane’s equation that is of little practical 
value for activated sludge modelling, which primarily uses substrate removal kinetics 
at low concentrations. It is the only one of the similar models, shown in Table  2.2. 
Table  2.2 : Model equations for substrate inhibition kinetics [36]. 
Equation No. Kinetic Model 
1  
I
S
IS
S
μ =μ
SK +S 1+ K
 
 
 

 
2 
 S
I 2
S
IS
S 1+S/K
μ =μ
SK +S+ K

 
3  
I 2
S
IS
S
μ =μ
S SK +S+ 1+K K
 
 
 

 
4 IS
-S/K
I
S
S
μ =μ e
K +S

 
6  IS S-S/K -S/KIμ =μ e e  
7a I
S
S
μ =μ
K +S

 when S < S*1 
7b  I IS
S
S
μ =μ -K S-S*
K +S

 when S < S* 
8 
α2
I
S m
S S
μ =μ  1-
K +S S

 
1S* = Treshold substrate concentration below which there is no substrate inhibition. 
2Sm = Substrate concentration above which growth is completely inhibited. 
Another modelling approach is presented for substrate inhibition, based upon the fact 
that sewage is not just a single substrate, but a mixture of substrate, and a minor 
IS
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fraction of this mixture may be expected to exhibit inhibiting properties. Generally, 
this can be reflected by (2.29): 
    S IS S S                                                               (2.29) 
where S is the total substrate concentration in sewage, and SS and SI its noninhibiting 
and inhibiting fractions respectively. This concept is introduced into the following 
model (2.30): 
     
ISK
I IES S SES                                                      (2.30) 
Proper manipulation of the model equations yields  (2.31): 
    
.IS I
S
IS
S
S S
K S
K
 
 

                                            (2.31) 
Equation (2.31) represents a very different biochemical mechanism for substrate 
inhibition in sewage treatment. It implies that the validity of using a single substrate 
approximation for substrate inhibition is more and more questionable for higher 
mixed liquor substrate concentrations and for lower inhibiting substrate fractions. 
This equation is also identical in format to the one derived for product inhibition 
because of the following reaction (2.32): 
     
PK
ES P ESP                                                       (2.32) 
For low substrate concentrations, where SKS, the rate expression for substrate 
utilization in the absence of inhibitors is reduced to Equation (2.33): 
    
S
dS
SX
dt YK

 

                                                      (2.33) 
The use of this equation modifies expressions (2.15) and (2.22), given for 
competitive and noncompetitive inhibitions respectively, into one single Equation 
(2.34): 
     .I
S I
KdS
S X
dt YK K I

 


                                        (2.34) 
Similarly, at high substrate concentrations where SKS, the acceptable 
approximation may be written as (2.35): 
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dS
X
dt Y

 

                                                           (2.35) 
which indicates that for SKS the impact of competitive inhibition may be ignored 
and that of noncompetitive inhibition may be reformulated as (2.36) [36]: 
    I
I
KdS
X
dt Y K I

 


                                                (2.36) 
2.5 Modelling of Activated Sludge 
A model can be defined as a purposeful and often simplified representation of a 
system of interest [35]. The use of dynamic models in activated sludge processes has 
become more widespread. Various mathematical models have already been 
developed to describe the process kinetics of microorganisms in an activated sludge 
process during the aerobic biodegradation of slowly as well as readily biodegradable 
substrates. Proper understanding of substrate removal mechanisms is very essential 
for modeling purposes. A multicomponent approach to the modelling of activated 
sludge provides the correct assessment of the viable biomass in the reactor as well as 
particulate inert fractions for the evaluation of the amount of sludge to be wasted 
from the system [36-38]. 
Activated Sludge Model No. 1 (ASM1), which is generally accepted as state-of-the-
art, presented by the IAWQ Task Group on Mathematical Modelling for Design and 
Operation of Biological Wastewater Treatment Processes is capable of simulating 
organic matter and nitrogen removal in different activated sludge processes [35,38].  
In addition to ASM1, Activated Sludge Model No. 3 (ASM3) includes storage of 
organic substrates as a new process. ASM3 proposed that all readily biodegradable 
substrate is firstly stored inside the cells and then storage products are reused for 
growth without addition of external substrate; however, biochemical modelling 
approaches accepted that growth and storage occur simultaneously [38,39]. 
Composition of biomass both in ASM3 and biochemical approach is shown in Figure 
2.7. 
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Figure  2.7 : (a) Composition of biomass in ASM3 (b) Composition of biomass in 
biochemical approach. 
In case of simultaneous growth and storage, there should be three different yield 
coefficients that are the yield for growth of biomass on substrate (YSX), the yield of 
storage on substrate (YSP) and the yield of growth on the stored substrate (YPX). If 
there is no simultaneous storage and growth, it is not necessary to define the yield for 
growth on external substrate [38]. 
2.5.1 Activated Sludge Model No.1 
Organik carbon removal can be modeled by using ASM1 and ASM3, which involve 
different processes. In ASM1, biomass is considered to grow solely on the external 
substrate present and the oxygen consumption after the external substrate depletion is 
explained with decay process. However, ASM1 could not explain the “tail” part of 
OUR profile that occurs during biodegradation of readily biodegradable substrates in 
batch experiments [36,37].  
In ASM1, COD is divided into fractions based on its solubility, biodegradability, 
biodegradation rate, and viability for biomass. The main COD fractions are defined 
as soluble (S), and particulate (X) COD. They are further divided into non-
biodegradable fraction and biodegradable fraction. The nonbiodegradable fraction is 
biologically inert and passes through an activated sludge system in an unchanged 
form. The inert soluble organic matter (SI) leaves the system at the same 
concentration as it enters. Inert particulate organic matter (XI) in the influent 
wastewater is removed with particulate organic matter produced via decay processes 
by sludge wastage [36]. 
Growth, decay and hydrolysis are basic processes which are involved in ASM1. 
According to the model, carbon removal is slightly coupled with nitrification. 
(b) 
Biomass 
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YSP Storage 
Polymer Biomass 
YPX 
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YSTO Storage 
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Heterotrophs utilize organic matter directly or after hydrolysis process whereas 
autotropic bacteria utilize ammonia for their growth. Decay of organisms results in 
particulate matter formation which in turn can be utilized for growth following 
hydrolysis [39]. 
The biodegradable matter is divided into soluble readily biodegradable (SS) and 
slowly biodegradable substrate (XS). Some of the XS is assumed soluble, and SS is 
assumed to be simple organic matter that is utilized by heterotrophic organisms for 
growth. On the other hand, regeneration of slowly biodegradable particulate matter 
on nonviable biomass is observed in death-regeneration model while the rest of it is 
converted to inert particulate product (XP). On the contrary, XS consists of relatively 
complex molecules that require enzymatic breakdown prior to utilization to SS such 
as hydrolysis. Heterotrophic biomass (XH) and autotrophic biomass (XA) are 
generated by growth on SS or growth on ammonia nitrogen (SNH). The biomass is lost 
via the decay process and converted to some other particulate components [39]. 
In endogenous decay model, SS is utilized in only growth process. In addition, 
generation of inert particulate products is linked to the active biomass decay, which a 
fraction of biomass (fEX) turns into XP. These products do not go any further reaction 
and accumulate in the system until they are removed by sludge wastage. On the other 
hand, soluble inert product formation is assumed through decay of a fraction of 
biomass (fES) [36]. 
The decrease of biomass can be given as (2.37) [40]: 
    
H PdX dXdX
dt dt dt
                                                  (2.37) 
bH is defined as the endogenous decay coefficient. The change in active biomass is 
expressed as (2.38): 
     H H H
dX
b X
dt
                                                        (2.38) 
Generation rate of particulate inert products are given in Equation (2.39): 
    P EX H
dX
f X
dt
                                                        (2.39) 
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When the maximum growth rate of heterotrophs and half saturation constant of 
substrate are defined as µH and KS respectively, biodegradation rate of SS which is 
directly used in growth is given in Equation (2.40): 
    
( )
S SH
H
H S S
dS S
X
dt Y K S



                                        (2.40) 
The decay associated soluble inert product formation rate can be given in Equation 
(2.41): 
    P ES H H
dS
f b X
dt
                                                     (2.41) 
Where KX and kh are maximum specific hydrolysis rate and half saturation 
coefficient for hydrolysis of slowly biodegradable substrate, hydrolysis of this 
fraction to SS is given in Equation (2.42): 
    
( / )
S S
h H
X S H
dX X
k X
dt K X X


                      (2.42) 
2.5.2 Activated Sludge Model No.3  
ASM3 has been proposed by IAWQ Task Group to establish the new concept in 
activated sludge modeling. While components and processes are similar to other 
activated sludge models, ASM3 includes storage process as well as products, and 
attains to estimate the oxygen consumption, sludge production, nitrification, and 
denitrification of activated sludge systems. In addition, ASM3 contains nitrogen and 
alkalinity limitation for growth of microorganisms with description of 
ammonification kinetics by assuming constant N and COD ratio [41]. 
The hydrolysis process has been very important in predicting the electron acceptor 
under aerobic and anoxic conditions. Whereas the quantification of the kinetic 
parameters for hydrolysis process was difficult, ASM3 simplified hydrolysis process 
by only one process independent of the electron acceptor. The model has also 
included the differences in decay rates of nitrifiers under aerobic and anoxic 
conditions [41]. 
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2.5.2.1 Components and processes of the model 
ASM3 integrated seven soluble and six particulate components to characterize the 
wastewater and activated sludge. Soluble and particulate components were 
distinguished by 0.45 μm membrane filtration [41]. 
The first component is dissolved oxygen (So), which can be directly measured and is 
subject to gas exchange. SI is a part of influent and may be produced by the 
hydrolysis of XS. SS is first taken up by heterotrophic organisms and stored as 
internal storage products (XSTO), then used for growth, according to ASM3. SS and SI 
are approximately equal to the total soluble COD determined by filtration from 0.45 
μm membrane filters. Ammonium plus ammonia nitrogen (SNH), dinitrogen (SN2) and 
nitrite plus nitrate nitrogen (SNO) is given as fractions of nitrogen. Alkalinity of the 
wastewater (SALK) is used to approximate the conservation of ionic charge in 
biological reactions [41]. 
XI is a part of influent and may be produced as a result of biomass decay. Bacteria 
cannot directly use the colloidal and particulate organic substrates, because they have 
high molecular weights. Therefore, XS must undergo hydrolysis before it is used by 
the biomass. The products of the hydrolysis are assumed to be readily biodegradable 
or soluble inert substrate. It must be reminded that all XS is contained in the influent 
and not involved in the filtrate of 0.45 μm membrane filters in ASM3. XH may grow 
both aerobically and anoxically. Hydrolysis does not consume any electron acceptor 
in ASM3. Active biomass is responsible for the hydrolysis of XS and storage process. 
XSTO, which is only defined as a functional component required for modeling but is 
not directly identifiable chemically consists of poly-β-hydroxylalkanoate (PHA), 
glycogen etc. XA oxidize the ammonium directly to nitrate, which is not considered 
in ASM3. Last component considered in model is the total suspended solids (XTS) 
that may be used for the modeling of volatile suspended solids (VSS) by some 
special ratios. There are twelve processes taken into account in ASM3 [41]. 
1. Hydrolysis: All of the slowly biodegradable substrates in the influent is converted 
to available soluble substrates. This process differs from ASM1 by being 
independent from electron acceptor. 
2. Aerobic storage of readily biodegradable substrate: All readily biodegradable 
substrate is assumed to be stored as XSTO, and then, ready to be used for the 
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growth of biomass. This conversion requires energy produced by aerobic 
respiration in the form of ATP. 
3. Anoxic storage of readily biodegradable substrate: This process is similar to 
aerobic storage, but energy requirement of this process is supplied by anoxic 
respiration. Due to less amount of denitrifiers, the process rate is naturally smaller 
than aerobic storage rate. 
4. Aerobic growth of heterotrophs: XSTO are assumed to be used as substrate for the 
growth of heterotrophs. 
5. Anoxic growth of heterotrophs: This process is identical with aerobic growth, but 
it is based on anoxic respiration. 
6. Aerobic endogenous respiration: This process, which is explained as all forms of 
biomass loss and energy requirements being not related to growth consists of 
decay, maintenance, endogenous respiration, lysis, predation, motility and death. 
7. Anoxic endogenous respiration: This process is similar to aerobic endogenous 
respiration, but it occurs at a slower rate. Especially protozoa predation is 
considerably less active under anoxic conditions than under aerobic conditions. 
8. Aerobic respiration of storage products: XSTO decay together with biomass like 
endogenous respiration. 
9. Anoxic respiration of storage products: Denitrifying conditions are applied for the 
similar process of aerobic respiration of XSTO. 
10. Aerobic growth of autotrophs: Nitrifiers oxidize ammonium directly to 
nitrate; nitrite, as an intermediate component, is not considered. 
11. Aerobic endogenous respiration for autotrophs: Apart from description for 
nitrifiers, it takes place similar to aerobic endogenous respiration. 
12. Anoxic endogenous respiration for autotrophs: It is similar to aerobic 
endogenous respiration for autotrophs, but it occurs at a slower rate. 
2.5.2.2 Process stoichiometry 
The net (true) yield of XH produced per unit of SS removed in ASM3 is found by 
Equations (2.43): 
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    2,2,2,
. OHOSTOOnet YYY               (2.43) 
All stoichiometric parameters of ASM3 are identified together with their units and a 
typical value in Table  2.3 [41]. 
Table  2.3 : Typical stoichiometric and composition parameters for ASM3. 
Symbol Characterization Value Units 
 
fSI 
Production of SI in 
hydrolysis 
0 g CODSI/(g CODXS)  
fXI 
Production of XI in 
endogenous respiration 
0.2 g CODXI/(g CODXBM)  
YSTO,O2 
Aerobic yield of stored 
product per SS 
0.85 g CODXSTO/(g CODSS) The values below are 
suggested if XSS is used 
to model VSS rather than 
SS: YH,O2 
Aerobic yield of 
heterotrophic biomass 
0.63 g CODXH/(g CODXSTO) 
iSS,XI SS to COD ratio for XI 0.75 g SS/(g CODXI) 0.75 g VSS/(g CODXI) 
iSS,XS 
SS to COD ratio for 
XS 
0.75 g SS/(g CODXS) 0.75 g VSS/(g CODXS) 
iSS,BM 
SS to COD ratio for 
biomass, XH, XA 
0.9 g SS/(g CODXBM) 
0.75 g VSS/(g 
CODXBM) 
2.5.2.3 Process kinetics 
In relation to removal of all soluble compounds, the kinetic expressions of ASM3 are 
relied on switching functions, which are hyperbolic or saturation terms, Monod 
equations, S/(K+S). Similarly, the switching functions are affected by particulate 
compounds with the ratio of XSTO/XH and XS/XH. All kinetic parameters of ASM3 
are given in Table  2.4. The units and typical values at 10°C and 20°C for these 
kinetic parameters are identified in Table  2.5 [41]. 
Interpolation of kinetic parameters k for different temperatures is proposed with 
Equation (2.44): 
          20 .exp . 20Tk T k C T C                       (2.44) 
where θT (in °C) may be found from (2.45): 
    
    
21
21 /ln
TT
TkTk
T 
              (2.45) 
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Table  2.4 : Kinetic rate expressions ρj for ASM3 All ρj ≥ 0. 
j Process Process rate equation ρj, for all ρj ≥ 0 
1 Hydrolysis 
 
  
Heterotrophic organisms, aerobic and denitrification 
2 
Aerobic storage of 
COD 
 
  
3 Aerobic growth 
 
 
 
  
4 
Aerobic endogenous 
respiration 
 
  
5 
Aerobic respiration of 
PHA 
 
  
According to ASM3, readily biodegradable substrate (SS) is best determined from 
bioassay in wastewater. Kinetics of the storage and growth processes are related to 
rapid uptake of oxygen after addition of wastewater to biomass. Therefore, the yield 
of storage process must be used to relate oxygen uptake to substrate consumption. 
This can be simulated with batch experiment for estimation of SS in ASM3 by 
Equation (2.46): 
  
   


STOO
SO
SO
SO
S
SS Y
dtr
dtrdtrbatchS
S
S
S
,2
2
2
1
.
..


                   (2.46) 
Table  2.5 : Typical values of kinetic parameters for ASM3. 
  
Temperature 
 
Symbol Characterization 10°C 20°C Units 
kH Hydrolysis rate constant 2 3 g CODXS/(g.CODXH).d 
KX Hydrolysis saturation constant 1 1 g.CODXS/(g.CODXH) 
Heterotrophic organisms XH, aerobic and denitrifying activity 
kSTO Storage rate constant 2.5 5 g CODSS/(g.CODXH).d 
KO2 Saturation constant for SNO2 0.2 0.2 g O2/m
3 
KS Saturation constant for substrate SS 2 2 g CODSS/m
3 
KSTO Saturation constant for XSTO 1 1 g.CODXSTO/(g.CODXH) 
μH 
Heterotrophic maximum growth rate of 
XH 
1 2 d-1 
bH,O2 
Aerobic endogenous respiration rate of 
XH 
0.1 0.2 d-1 
bSTO,O2 Aerobic respiration rate for XSTO 0.1 0.2 d
-1 
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2.5.3 Metabolic models 
A metabolic model is based on the principle that the metabolism of organism is 
composed of a limited number of metabolic pathways which results in more or less 
constant energy requirement and ultimately constant stoichiometry [42]. Metabolic 
pathways are described with internal reactions that are combined with reaction 
stoichiometry and degree of reduction balances to derive the linear equation for 
description of involved metabolism.  
Since biological wastewater treatment processes generally occur under dynamic 
conditions, microorganisms have experience rapidly changing conditions of 
availability of nutrients. The response of microorganisms to feast/famine conditions 
is regularly the accumulation of storage polymers like PHA and glycogen. A 
metabolic model was proposed that as a carbon source, acetate is aerobically stored 
as PHB under dynamic conditions. This metabolic model reduces the number of 
unknown parameters and describes the observed kinetics of PHB formation and 
consumption by selected microorganism [42].  
The substrate uptake rate will be larger than required for growth when carbon source 
is given periodically. It is observed that the fast uptake of substrate results in the 
formation of NADH2 which is consumed by oxidative phosphorylation and leading 
to ATP formation. If the energy requirement for growth is limited, ATP will 
accumulate by resulting in NADH2 accumulation in turn. This explains that the 
production of a more reduced storage polymer PHB (requires NADH2) is more likely 
to be compared with the production of glycogen (leads to NADH2 formation) [42]. 
In this metabolic model, acetate limited continuous culture of Paracoccus 
pantotrophus sp. was used in order to observe the metabolism of a microorganisms 
capable of producing and consuming which was described by seven internal reaction 
in Figure  2.8. Biomass is assumed to contain two different parts as an active biomass 
compartment (1-fPHB = capable of reproduction and growth) and PHB fraction (fPHB = 
used as storage for carbon and energy) [42]. 
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Figure  2.8 : Schematic representation of the metabolism of an organism capable of 
forming and consuming PHB [42]. 
Synthesis of Acetyl-CoA from Acetate, (r1): Acetate is taken into cell by active 
transport, Acetyl-P is formed and at last, conversion to Acetyl-CoA is completed. 
Synthesis of biomass monomers from Acetyl-CoA, (r2): This is the first part of the 
synthesis of active biomass. 
Polymerization of biomass precursors and maintenance, (r3): The biomass 
precursors are polymerized into active biomass and thus, biomass formation is 
completed. 
Carbon source catabolism, (r4) 
Oxidative phosphorylation, (r5): ATP is produced from NADH2. 
Synthesis of the storage product PHB from Acetyl-CoA, (r6): The substrate is 
used for the synthesis of both biomass and PHB. 
Synthesis of Acetyl-CoA from PHB, (r7): In the absence of acetate, the 
microorganisms utilize the intracellular accumulated PHB as carbon and energy 
source. The storage polymer is hydrolyzed and converted into Acetyl-CoA [42]. 
The metabolic model results in two equations describing the conversion processes for 
feast and famine phases. For the feast period, the linear equation describing acetate 
uptake, biomass growth, PHB production and maintenance is defined as in Equation 
(2.47) [42]: 
    XSP
SP
X
SX
S Cmr
Y
r
Y
r 
maxmax
11
)(                       (2.47) 
where, 
    
32.413.4
24max





SXY                                               (2.48)       
 
32
    


5.4
24max SPY                         (2.49) 
    
12 


ATP
S
m
m                          (2.50) 
Similarly, PHB consumption, biomass growth, and maintenance are expressed with 
Equation (2.51) for the famine period: 
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The linear equations contain two unknown parameters namely, the ratio between 
ATP produced and electrons transferred from NADH2 to an electron acceptor (δ) and 
the ATP consumption due to maintenance processes (mATP). Substition of rX=μ.CX, 
rS=qS.CX, and rP=qP.CX followed by division by the biomass concentration, CX gives 
the following Equation (2.54): 
    SP
SPSX
S mq
YY
q 
maxmax
11
)(                        (2.54) 
From earlier experiments, it was observed that maximum yield of biomass on 
acetate, YSX
max=0.45 (C-mol/C-mol) and maintenance coefficient for growth on 
acetate mS=0.038 (C-mol/C-mol.h) [43]. The P/O ratio, δ=1.84 (mol ATP/mol 
NADH2) and the ATP maintenance coefficient, mATP=0.102 (mol ATP/C-mol.h) 
were calculated by using Equations (2.48) and (2.50). Maximum yield of PHB on 
acetate was found as YSP
max=0.648 (C-mol/C-mol) by using Equation (2.49). 
Substituting these yield coefficients in Equation (2.54) gives Equation (2.55): 
    2.22 . .544 0.038S Pq l q               (2.55) 
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From the carbon balance and the degree of reduction balance relations for the 
specific carbon dioxide production rate (qC) and for the specific oxygen consumption 
rate (qO) can be derived as a function of μ and qP in Equations (2.56) and (2.57): 
     (- ) - - 1.22 0.544 0.038C S P Pq q q q             (2.56) 
    ( ) 1.188 0.419 0.038O Pq q               (2.57)          
Stoichiometry of the kinetic model for the PHB production can be based upon 
Equations (2.55)-(2.57). 
Maximum yield of biomass on PHB, YPX
max =0.653 [C-mol/C-mol] and maintenance 
coefficient for growth on PHB, mP=0.0131 [C-mol/C-mol.h] were calculated for the 
famine phase. The linear Equaiton (2.58) describes PHB consumption and growth: 
    P
PX
P m
Y
q  
max
1
)(                         (2.58) 
    1.532 0.0131Pq                           (2.59)  
From the carbon balance and the degree of reduction balance relations for the 
specific carbon dioxide production rate (qC) and for the specific oxygen consumption 
rate (qO) can be derived in Equations (2.60) and (2.61): 
     0.532 0.0131Cq                        (2.60)        
    ( ) 0.693 0.0147Oq                           (2.61)              
Stoichiometry of the kinetic model for the PHB consumption can be based upon 
Equations (2.59)-(2.61). 
It was observed from experimental and modelling results that, the substrate uptake 
rate reaches its maximum value immediately after the pulse addition. However, the 
growth rate is influenced only by maximal growth rate, and slowly decreases during 
growth on PHB presumably being related to the reduction in PHB amount [42]. In 
these cases, the storage polymers act as a buffer for the substrate that is taken up but 
not directly used for growth. The more the microorganisms are able to store during 
the feast period and subsequently use it for growth, the more they have a competitive 
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advantage [42,44]. Therefore, for WWTPs it can be discussed that under dynamic 
conditions microorganisms accumulate more substrate and outcompete organisms 
that do have lower substrate uptake rates. 
Another metabolic model for PHB metabolism in aerobic, slow growing activated 
sludge culture has been proposed for definition of relation between the PHB storage 
and activated sludge models. The metabolic model is the same as described by van 
Aalst-van Leeuwen et al., (1997) with the exception of biomass composition. It is 
found that bacteria can balance their growth rate with respect to dynamic substrate 
feeding, using the PHB metabolism and regulate the substrate uptake rate. Therefore, 
bacteria can compete effectively for substrate. While acetate is taken up with 
maximum specific substrate uptake rate, which is dependent on the SRT, PHB is 
produced with a constant rate in the feast period. The difference in specific growth 
rate between the feast and famine period reduces with increasing SRT. Biomass 
growth on PHB leads to only 4-10% lower biomass yield than the direct utilization of 
acetate for growth. On the other hand, PHB synthesis process consumes 66 to almost 
100% of the acetate by increasing the COD need compared to a situation without 
storage, the rest of the acetate is used for growth and maintenance [45]. 
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3 MATERIALS AND METHODS 
3.1 Experimental Approach 
In order to assess the biological treatability of the chosen antibiotics and verify the 
change in the kinetic parameters, such as growth rate, a laboratory scale batch reactor 
was operated under aerobic condition. The system had a total reactor volume, VT, of 
10 l, where 5 l functioned as the stationary volume, V0, holding settled biomass and 
the remaining 5 l as the fill volume, VF, corresponding to a V0/VF ratio of 1.0. It was 
started using the activated sludge taken from a domestic WWTP as inoculum. Firstly, 
microbial culture was acclimated in the fill and draw reactor at a sludge retention 
time of 10 d with readily biodegradable substrate. The acetate was chosen as sole 
readily biodegradable carbon source. 
After the acclimation of biomass to acetate as a sole carbon source, fate and effect of 
the SMX on activated sludge was investigated. The acclimated microbial community 
taken from the reactor was primarily used as the biomass seed for acute inhibition 
studies in respirometric experiments. All the experiments involved a number of batch 
reactors initially inoculated with the same microbial culture from the main reactor 
and started with and without antibiotic additions (control).  
The impact of the selected antibiotic at different concentrations was evaluated with 
the respirometric tests for generating the OUR profiles corresponding to selected 
initial conditions. To inhibit nitrification, 1.04 g Allyl Thio Urea (ATU) was added 
to the batch reactor of the respirometer. In the acute inhibition studies, four runs were 
applied for SMX as 25 mg/l, 50 mg/l, 100 mg/l and 200 mg/l. 
As a second step, after the acute tests were completed, an antibiotic reactor was set 
up in addition to the control reactor (Figure  3.1). In order to determine the effect of 
continuous exposure to antibiotic SMX, the chronic inhibition studies were carried 
out by feeding the mixed culture with combination of the acetate and the antibiotic 
compound. During the chronic inhibition studies, the influent SMX concentration 
was applied as 50 mg/l.  
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Figure  3.1 : Picture of the SBRs, both control (right) and antibiotic (left). 
3.2 Reactor Operation 
The batch reactor were operated until it reached steady state conditions, which was 
monitored by suspended solids (SS), volatile suspended solids (VSS) and COD 
parameters. At the steady state conditions, VSS concentration was kept in the range 
of 1500-1700 mg VSS/l. The sodium acetate was used as synthetic substrate and the 
initial carbon concentration was kept as 400 mg COD/l. By the way, the substrate 
solution was prepared to contain in one litter; 95 g of sodium acetate. Besides the 
organic carbon source, all other macro and micro nutrients were supplied for the 
nutritional needs of the cells and to provide enough buffer capacity to the reactor so 
that pH is kept at a range of 6.5–7.5. The composition of the nutrients fed to the 
system is given Table  3.1 [46]. 
Table  3.1 : Composition of sodium acetate solution, solution A and solution B. 
Compound Feed Concentration (g/L) 
Acetate solution  
CH3COONa 95 
Solution A  
KH2PO4 160 
K2HPO4 320 
NH4Cl 120 
Solution B  
MgSO4.7H2O 15 
FeSO4.7H2O 0.5 
ZnSO4.7H2O 0.5 
MnSO4.H2O 0.41 
CaCl2.2H2O 2.65 
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During each daily feeding period, reactor was settled for 0.5 h (ts) and decanted until 
5 l (V0). Aeration was continuously provided and the oxygen concentration in the 
reactor was kept at minimum of 2 mg/l to maintain aerobic conditions. Furthermore, 
the temperature of system was kept at around 20± 1°C.  
3.3 Analytical Procedures 
The SBR was monitored and controlled with regular measurements of SS, VSS, 
COD and PHA. All analyses were conducted in duplicate. Since the formation of 
PHB from the central metabolite acetyl-CoA, is the main storage polymer, PHA 
measurements mainly consisted of PHB, and therefore the results of experiments in 
fact represent PHB as storage compound.  
In the experiments, pH was kept in the range of 6.5–7.5, suitable for biological 
activity. pH measurements were performed by an Orion 520 Aplus pH meter. 
Temperature of all experiments was maintained at 20±1°C. Samples, which were 
taken for soluble COD and antibiotic, were filtered through Millipore membrane 
filters with a pore size of 0.45 µm to separate the bacterial cells from the liquid. PHB 
samples were taken from complete mixing via clipped pipette. COD samples were 
preserved with sulfiric acid (H2SO4), PHB samples with sodium hypochlorite 
(NaClO) solution and antibiotic samples without any addition. 
COD measurements were performed as described in the method proposed by 
ISO6060 [47]. The Millipore AP40 glass fiber filters were used for SS and VSS 
measurements that were performed as defined in Standard Methods [48].  
In order to determine the storage properties of the activated sludge, PHB amounts in 
the sludge were assessed according to gas chromatographic (GC) method, which is 
characterized by high accuracy and excellent reproducibility, permitting 
determinations as low as 10-5 g/l. The basis of the method is to depolymerise and 
dehydrate PHB by H2SO4. PHB samples were taken 8 ml into centrifuge tubes 
containing 2 ml NaClO solution for preventing the biological activity. The tubes 
were centrifuged 30 min at 5000 rpm and after discarding supernatant, the 
centrifuged samples were suspended in a mixture of 2 ml methanol acidified with 
H2SO4 (3% v/v). The retained biomass pellets were put into glass tubes by adding 2 
ml of chloroform to each. The mixture in the tubes were subject to extraction and 
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hydrolization at 100°C for 4h and subsequently cooled back to room temperature. 
After cooling, 1 ml of deionised water was added to each sample and the samples 
were shaken vigorously for 10 min. to remove free acids in resulting organic phase. 
The two phases were allowed to separate for 24 h. After phase separation, the 
organic phase was transferred directly into standard 2 ml vials and measured by 
Agilent 6890N GC. Within the linear range of the detector used on GC apparatus, the 
results of this method depend neither on the volume of the cell suspension nor on the 
PHB content of the cells; the maximum standard deviation was ± 0.5% [49]. 
3.4 Biodegradation Test 
Since the main aim of this study was to enlighten the treatment mechanism and the 
effects of antibiotic compound on activated sludge systems, antibiotic concentrations 
were chosen higher than that of in domestic wastewaters. Determination of SMX was 
performed by using High Performance Liquid Chromatography (HPLC) at 280 nm. 
Measurement methodology for antibiotic compounds has 3 steps, which were 
sampling, sample preparation and preservation (filtering, pH adjustment and 
prevention of photo-degradation). For the measurement in water phase, the SMX 
samples filtered through 0.45 µm Milipore membrane filters were transferred to 
HPLC vials. 
The adsorped part of SMX onto activated sludge was also investigated. Separation of 
the antibiotic from the activated sludge on which it may be absorbed was applied by 
ultrasonication process via an ultrasonicator. Ultrasonication resulted in release of 
SMX residues to the liquid phase from which SMX samples were collected. Then, 
the samples were centrifuged for 10 min at 5000 rpm. The supernatant was filtered 
through 0.45 µm Milipore membrane filters and analyzed by HPLC. For specific 
SMX analyses, Novapak C18 column was used with HPLC. Mobile phase 
composition was 30:70 v/v methanol-water mixture [50]. Mobile phase was acidified 
with phosphoric acid (0.1%) at pH 2.5 and flowed with 1 ml/min. Injection volume 
was 40 µl. Calibration curve used for the determination of SMX with Diode Array 
Detector at 280 nm is given in Figure  3.2. 
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Figure  3.2 : Calibration curve for determination of SMX. 
In the biodegration tests, acetate solution acclimated sludge was used. Organic 
loading rate (OLR) was kept as same with the main reactor throughout the 
respirometric analysis.  
3.5 Respirometric Analysis 
OUR equipment, also known as respirometer, can range from a basic system which 
requires manual data collection and calculation to more advanced commercial 
systems where calculations are automated. Regardless of the level of automation, the 
OUR equipment has essential components which include a test chamber to add 
aerated mixed liquor/substrate, a stirring mechanism, a dissolved oxygen (DO) 
probe, and a DO analyzer.  
Respirometric tests were conducted to determine the degradation profile of the 
readily biodegradable substrate (acetate) and latter both acute and chronic inhibition 
effects of the chosen antibiotics on the control sludge. The respirometric tests were 
conducted with relevant acclimated biomass seeding alone to obtain endogenous 
OUR level of biomass. Samples with same OLR with main reactor were added to the 
batch reactor and the OUR data was monitored. For monitoring the OUR, part of the 
contents of the batch reactor (volume 400-500 ml) was sucked out to the airtight DO 
monitoring chamber. The DO decrease in the DO monitoring chamber was 
monitored with a pre-calibrated DO probe and the output was recorded. This 
operation was continuously performed to obtain the DO profile decreasing with time. 
The OUR was calculated by the measuring the slope of the DO decrease on the plot. 
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OUR measurements were performed with an Applitek RA-Combo-1000 continuous 
respirometer. In all respirometric experiments, twelve samples were taken with 
respect to time till the end of the experiment. Time durations and monitored data for 
experimental runs were given in Table  3.2. 
Table  3.2 : Monitored data for experimental runs. 
Time pH SS/VSS 
COD 
filtered 
SMX 
filtered 
SMX in 
the sludge 
PHB 
-20 min X X X X X X 
15 min   X X  X 
30 min   X X  X 
45 min   X X  X 
60 min   X X  X 
80 min   X X  X 
100 min   X X  X 
120 min   X X  X 
160 min   X X  X 
200 min   X X  X 
240 min   X X  X 
24 h   X X X X 
The summary of acute respirometric studies performed with SMX is given in Table 
 3.3. In these experiments, F/M ratio was again kept constant as in the antibiotic 
reactor, but both VSS and substrate concentrations were diluted by 1/2 ratio. 
Table  3.3 : Influent conditions for acute respirometric analyses. 
Set No. Experiment 
MLVSS 
(mg/l) 
Initial acetate 
(mg COD/l) 
Initial SMX 
(mg COD/l) 
Initial SMX 
(mg SMX/l) 
Set 1 Control 900 246 - - 
Set 2 SMX-25 1000 200 34 25 
Set 3 SMX-50 800 200 69 50 
Set 4 SMX-100 930 200 138 100 
Set 5 SMX-200 900 200 276 200 
The chronic effect of SMX on the treatment efficiency and bacterial behaviour was 
evaluated with performing the respirometric analysis throughout 30 d from the start 
up of the chronic acclimation to mixture of 70 mg COD/l of SMX and 200 mg 
COD/l of acetate. The influent concentrations of the chronic respirometric test were 
summarized in Table  3.4. 
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Table  3.4 : Influent conditions for chronic respirometric analyses. 
Set 
No. 
Day 
No. 
Substrate type 
MLVSS 
(mg/l) 
Initial acetate 
(mg COD/l) 
Initial SMX 
(mg COD/l) 
Initial SMX 
(mg SMX/l) 
Set 3 1 Acetate + Antibiotic 800 200 69 50 
Set 6 5 Acetate + Antibiotic 880 200 69 50 
Set 7.1 10 Acetate + Antibiotic 865 200 72 50 
Set 7.2 10 Acetate 865 200 - - 
Set 7.3 10 Antibiotic 865 - 72 50 
Set 8 15 Acetate + Antibiotic 820 200 72 50 
Set 9.1 20 Acetate + Antibiotic 820 50 70 50 
Set 9.2 20 Acetate 820 50 - - 
Set 9.3 20 Antibiotic 820 - 70 50 
Set 10 25 Acetate + Antibiotic 800 50 71 50 
Set 11.1 30 Acetate + Antibiotic 850 50 71 50 
Set 11.2 30 Acetate 850 50 - - 
Set 11.3 30 Antibiotic 850 - 71 50 
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4 RESULTS AND DISCUSSION 
4.1 Acclimation Studies of Control Reactor 
Acclimation studies were run for each feeding pattern. For this purpose, total 
suspended solids (SS) and volatile suspended solids (VSS) content of biomass were 
measured. After the acclimation period, both SS and VSS concentrations became 
constant with time. The results of these measurements were given in Figure  4.1. 
 
Figure  4.1 : SS, VSS results of the control reactor during the acclimation period. 
SBR operation reached to steady state after 90 days, approximately 10 sludge ages. 
At the steady state condition, average SS and VSS concentrations were found as 
2260 mg SS/l and 1650 mg VSS/l respectively. According to these results, 70-75% 
average VSS/SS ratio was found. Soluble COD effluent concentration during the 
acclimation period was given in Figure  4.2. When the steady state condition 
prevailed, effluent COD results became in the range of 30-45 mg COD/l. 
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Figure  4.2 : Soluble COD effluents of the control reactor during the acclimation 
period. 
4.2 Experimental Results 
First the performance control reactor was determined during several cycles by using 
only acetate as substrate under aerobic conditions, and then, the batch tests were 
applied in order to investigate the acute and chronic inhibition effects of SMX. In 
these experiments, F/M ratio was kept constant, but both VSS and substrate 
concentrations were diluted by 1/2 ratio. Therefore, the acetate concentration was 
200 mg COD/l and the VSS concentration was approximately 800-900 mg VSS/l in 
the experiments. OUR profile and soluble COD profile of the control reactor were 
given in Figure  4.3 and Figure  4.4, respectively. 
 
Figure  4.3 : OUR profile of the control experiment versus time (Set 1). 
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The shoulder on the OUR curve observed from the beginning of the famine period 
would normally be associated with utilization of storage products as substrate 
according to principles of ASM3 [24]. Since only acetate was added in this 
experiment, this shoulder was presumably due to the stored PHB. Total area under 
the OUR curve, which gives total dissolved oxygen concentration (DOTotal), was 
calculated as 218 mg O2/l including a 156 mg O2/l dissolved oxygen concentration 
used for endogenous respiration (DOEndo). 
 
Figure  4.4 : Soluble COD profile of the control experiment versus time. 
4.2.1 Acute experiments 
The acute experiments conducted by pulse feeding of the SMX were done with 
sludge acclimated to instant acetate feeding in the beginning of each cycle, under 
aerobic conditions. Four different concentrations of SMX, which were 25 mg/l, 50 
mg/l, 100 mg/l and 200 mg/l were applied to observe the acute inhibition effects of 
the antibiotic. OUR profile of the first acute experiment (Set 2) was given in Figure 
 4.5.  
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Figure  4.5 : OUR profile versus time (Set 2). 
In this experiment, DOTotal and DOEndo were calculated as 263 mg O2/l and 108 mg 
O2/l, respectively. Since there was not SMX removal in the acute experiments, the 
removal of acetate was also calculated by substracting the COD of SMX from total 
soluble COD. Soluble COD & SMX profiles of the acute experiment, SMX-25 were 
given in Figure  4.6. 
 
Figure  4.6 : Soluble COD & SMX profiles of Set 2 (SMX-25 mg/l). 
OUR profile and soluble COD profile of the second acute experiment (Set 3) were 
given in Figure  4.7 and Figure  4.8, respectively. In this experiment, DOTotal and 
DOEndo were calculated as 182 mg O2/l and 96 mg O2/l. 
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Figure  4.7 : OUR profile versus time (Set 3). 
 
Figure  4.8 : Soluble COD & SMX profiles of Set 3 (SMX-50 mg/l). 
OUR profile and soluble COD profile of the third acute experiment (Set 4) were 
given in Figure  4.9 and Figure  4.10, respectively. In this experiment, DOTotal and 
DOEndo were calculated as 211 mg O2/l and 84 mg O2/l. 
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Figure  4.9 : OUR profile versus time (Set 4). 
 
Figure  4.10 : Soluble COD & SMX profiles of Set 4 (SMX-100 mg/l). 
OUR profile and soluble COD profile of the last acute experiment (Set 5) were given 
in Figure  4.11 and Figure  4.12, respectively. In this experiment, DOTotal and DOEndo 
were calculated as 270 mg O2/l and 149 mg O2/l. 
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Figure  4.11 : OUR profile versus time (Set 5). 
 
Figure  4.12 : Soluble COD & SMX profiles of Set 5 (SMX-200 mg/l). 
Comparison of all acute experiments with respect to the OUR profiles was given in 
Figure  4.13. As shown in figure, the OUR curves decreased by increasing the given 
SMX concentration. 
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Figure  4.13 : Comparison of OUR profiles of all acute experiments with the control. 
4.2.2 Chronic experiments 
In order to investigate chronic inhibition effecs of the SMX, a second SBR was set 
up and fed by the antibiotic in addition with the acetate. A 50 mg SMX/l 
(approximately 70 mg COD/l) was given to the reactor with the same amount of 
acetate (400 mg COD/l). Performance of the antibiotic reactor was followed by 
monitoring SS and VSS concentrations as well as by taking COD and SMX samples 
regularly. The results of these measurements were given in Figure  4.14 and Figure 
 4.15, respectively. 
 
Figure  4.14 : SS, VSS results of the antibiotic reactor versus time. 
After the fifteenth day, the VSS concentration was started to decrease and therefore, 
the VSS/SS ratio decreased. 
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Figure  4.15 : COD & SMX results of the antibiotic reactor versus time. 
Several batch tests were conducted by using both acetate and antibiotic (called as 
mix), only acetate and only antibiotic as substrate under aerobic conditions. In these 
experiments, F/M ratio was again kept constant as in the antibiotic reactor, but both 
VSS and substrate concentrations were diluted by 1/2 ratio. The chronic experiments 
were applied as; 
 on the first day of antibiotic feeding  one experiment with mixed substrate 
 on the fifth day of antibiotic feeding  one experiment with mixed substrate 
 on the tenth day of antibiotic feeding  three experiments with mixed 
substrate, only acetate and only SMX 
 on the fifteenth day of antibiotic feeding  one experiment with mixed 
substrate 
 on the twentieth day of antibiotic feeding  three experiments with mixed 
substrate, only acetate and only SMX 
 on the twenty fifth day of antibiotic feeding  one experiment with mixed 
substrate 
 on the thirtieth day of antibiotic feeding  three experiments with mixed 
substrate, only acetate and only SMX 
OUR profile and soluble COD profiles including SMX data of the first day 
experiment, in which the acute experiment SMX-50 (Set 3) was taken, were given in 
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Figure  4.16 and Figure  4.17, respectively. In this experiment, DOTotal and DOEndo 
were calculated as 182 mg O2/l and 96 mg O2/l.  
 
Figure  4.16 : OUR profile versus time (Set 3). 
At the beginning of the chronic experiments, SMX removal was not observed as in 
the acute experiments. Therefore, both acetate and SMX concentrations in mg COD/l 
were also given in soluble COD profiles. 
 
Figure  4.17 : Soluble COD & SMX profiles of Set3. 
OUR profile of fifth day experiment was given in Figure  4.18. In this experiment, 
DOTotal and DOEndo were calculated as 96 mg O2/l and 34 mg O2/l. Soluble COD and 
SMX profiles of Set 6 was given in Figure  4.19. The measured SMX concentrations 
were higher than the fed to the reactor (50 mg SMX/l) due to the accumulation of 
antibiotic through five days. 
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Figure  4.18 : OUR profiles versus time (Sets 6). 
 
Figure  4.19 : Soluble COD & SMX profiles of Set 6. 
OUR profiles of tenth day experiments were given in Figure  4.20. As shown in 
figure, OUR curve of Set 7.1 was lower than OUR curve of Set 7.2. DOTotal and 
DOEndo were calculated as 109 mg O2/l and 34 mg O2/l for Set 7.1; 119 mg O2/l and 
31 mg O2/l for Set 7.2; 45 mg O2/l and 45 mg O2/l for Set 7.3. The same oxygen 
consumption showed that the biomass did only endogenous respiration in Set 7.3. 
Soluble COD and SMX profiles of Set 7.1, Set 7.2 and Set 7.3 were given in Figure 
 4.21, Figure  4.22 and Figure  4.23, respectively. 
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Figure  4.20 : OUR profile versus time (Set 7.1, Set 7.2 & Set 7.3). 
 
Figure  4.21 : Soluble COD & SMX profiles of Set 7.1. 
 
Figure  4.22 : Soluble COD & SMX profiles of Set 7.2. 
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Figure  4.23 : Soluble COD & SMX profiles of Set 7.3. 
OUR profile and soluble COD profiles including SMX data of Set 8 were given in 
Figure  4.24 and Figure  4.25, respectively. In this experiment, DOTotal and DOEndo 
were calculated as 119 mg O2/l and 35 mg O2/l. On the fifteenth day, approximately 
20% of SMX removal was observed as shown in Figure  4.25. 
 
Figure  4.24 : OUR profile versus time (Set 8). 
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Figure  4.25 : Soluble COD & SMX profiles of Set 8. 
OUR profiles of three experiments (Set 9.1, Set 9.2 & Set 9.3) done on the twentieth 
day were given in Figure  4.26. As shown in figure, OUR curves of Set 9.1 and Set 
9.2 were close to each other. DOTotal and DOEndo were calculated as 51 mg O2/l and 
17 mg O2/l for Set 9.1; 31 mg O2/l and 14 mg O2/l for Set 9.2; 26 mg O2/l and 9 mg 
O2/l for Set 9.3. 
 
Figure  4.26 : OUR profiles versus time (Set 9.1, Set 9.2 & Set 9.3). 
Soluble COD and SMX profiles of Set 9.1, Set 9.2 and Set 9.3 were given in Figure 
 4.27, Figure  4.28 and Figure  4.29, respectively. On the twentieth day, SMX removal 
increased with respect to the previous experiments, as shown in Figure  4.27. 
Furthermore, in Set 9.2 and Set 9.3 effluent SMX concentrations decreased up to 
zero. 
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Figure  4.27 : Soluble COD & SMX profiles of Set 9.1. 
 
Figure  4.28 : Soluble COD & SMX profiles of Set 9.2. 
 
Figure  4.29 : Soluble COD & SMX profiles of Set 9.3. 
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OUR profile and soluble COD profiles including SMX data of Set 10 were given in 
Figure  4.30 and Figure  4.31, respectively. In this experiment, DOTotal and DOEndo 
were calculated as 59 mg O2/l and 21 mg O2/l. 
 
Figure  4.30 : OUR profile versus time (Set 10). 
Since a complete SMX removal was observed on the twentieth day, after that SMX 
decreased to zero in the following experiments.  
 
Figure  4.31 : Soluble COD & SMX profiles of Set 10. 
OUR profiles of three experiments (Set 11.1, Set 11.2 & Set 11.3) done on the 
thirtieth day were given in Figure  4.32. As shown in figure, OUR curves of Set 11.1 
was lower than OUR curve of Set 11.2. DOTotal and DOEndo were calculated as 64 mg 
O2/l and 32 mg O2/l for Set 11.1; 76 mg O2/l and 29 mg O2/l for Set 11.2; 113 mg 
O2/l and 63 mg O2/l for Set 11.3. 
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Figure  4.32 : OUR profiles versus time (Set 11.1, Set 11.2 & Set 11.3). 
Soluble COD and SMX profiles of Set 11.1, Set 11.2 and Set 11.3 were given in 
Figure  4.33, Figure  4.34 and Figure  4.35, respectively. 
 
Figure  4.33 : Soluble COD & SMX profiles of Set 11.1. 
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Figure  4.34 : Soluble COD & SMX profiles of Set 11.2. 
 
Figure  4.35 : Soluble COD & SMX profiles of Set 11.3. 
Comparison of the OUR profiles of all chronic experiments (with mixed substrate, 
with only acetate and with only antibiotic) were indicated in Figure  4.36, Figure  4.37 
and Figure  4.38, respectively.  
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Figure  4.36 : Comparison of the OUR profiles of all chronic experiments (with 
mixed substrate). 
 
Figure  4.37 : Comparison of the OUR profiles of all chronic experiments (with only 
acetate). 
The trend of the OUR profiles obtained in only antibiotic fed experiments were 
completely different from the addition of only acetate and mixed substrate. 
Although there was not any antibiotic removal on the acclimation period of ten 
days, SMX biodegradation was observed on the twentieth day experiment as shown 
in Figure  4.38. 
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Figure  4.38 : Comparison of the OUR profiles of all chronic experiments (with only 
SMX). 
4.3 Modelling of Experimental Results 
A mechanistic model involving model components and kinetic parameters was 
developed for both acetate and SMX. The AQUASIM simulation program was 
used in modeling studies. This model was calibrated with related experimental data 
such as OUR and PHB. Biodegradation characteristics and kinetics of acetate and 
SMX were estimated. The evaluation of calibrated model indicated that a group of 
microorganisms adjusted their enzymatic tools for the utilization of SMX at high 
sludge age (10 days). The matrix representation of modified ASM3 structure was 
indicated in Table  4.1. 
Table  4.1 : Matrix representation of modified ASM3 structure [51]. 
Process SS SO XP XH XSTO Rate Equation 
Aerobic storage 1  
(1 )STOY 
 
  STOY  
S O
STO H
S S O O
S S
k X
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Model simulation results of Set 1 according to modified ASM3 were indicated in 
Figure  4.39 and Figure  4.40, respectively. 
 
Figure  4.39 : Model simulation of OUR data for Set 1. 
 
Figure  4.40 : Model simulation of PHB data for Set 1. 
In the acute experiments, model simulation was applied to all acute experimental 
results. Since there were not PHB samples in Set 2, model simulation of PHB data 
could not be done. Model simulation result of OUR data for Set 2 was shown in 
Figure  4.41. 
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Figure  4.41 : Model simulation of OUR data for Set 2. 
Model simulation results of OUR data and PHB data for Set 3 were indicated in 
Figure  4.42 and Figure  4.43, respectively. 
 
Figure  4.42 : Model simulation of OUR data for Set 3. 
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Figure  4.43 : Model simulation of PHB data for Set 3. 
Model simulation results of OUR data and PHB data for Set 4 were illustrated in 
Figure  4.44 and Figure  4.45 respectively. 
 
Figure  4.44 : Model simulation of OUR data for Set 4. 
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Figure  4.45 : Model simulation of PHB data for Set 4. 
Since there were not PHB samples in Set 5, model simulation of PHB data could 
not be done. Model simulation result of OUR data for Set 5 was given in Figure 
 4.46. 
 
Figure  4.46 : Model simulation of OUR data for Set 5. 
Modelling results of modified ASM3 indicated that maximum heterotrophic growth 
rate (μH), maximum growth rate on the stored products (µSTO), and half saturation 
constant for readily biodegradable substrate (KS) were the same for all acute 
experiments with control experiment. According to the simulation results, 
endogenous decay rate (bH) was 0.2 d
-1 for the control experiment whereas it was 
found 0.45 d-1 for the acute experiments. Half saturation constant for storage (KSTO) 
also increased in the acute experiments based on model simulation, when compared 
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to the value in the control experiment. On the other hand, a considerable decrease 
of maximum storage rate (kSTO) was observed from 5.7 d
-1 to 3 d-1 in the acute 
experiments. The model simulation results based on modified ASM3 of Set 1, Set 
2, Set 3, Set 4 and Set 5 were given in Table  4.2. 
Table  4.2 : Results of model calibration for the acute SMX experiments. 
 Assumptions: YH = 0.66 g COD/g COD and YSTO = 0.8 g COD/g COD [52,53]. 
In the chronic experiments, only the first day mix (Set 3); fifteenth day mix (Set 8); 
twentieth day mix, acetate and antibiotic (Set 9.1, Set 9.2 & Set 9.3) were simulated 
by the modified ASM3 model. 
Model simulation results of Set 3 were represented in Figure  4.42 and Figure  4.43, 
respectively. 
Since there were not PHB samples in Set 8, model simulation of PHB data could 
not be done. Model simulation result of Set 8 was shown in Figure  4.47. 
Model 
Parameters 
Unit Control 
Acute 
SMX-25 
Acute 
SMX-50 
Acute 
SMX-100 
Acute 
SMX-200 
μH 1/day 3.5 3.5 3.5 3.5 3.5 
KS mg COD/l 6.0 6.0 6.0 6.0 6.0 
bH   1/day 0.2 0.45 0.45 0.45 0.45 
kSTO 1/day 5.7 3.0 3.0 3.0 3.0 
µSTO 1/day 3.5 3.5 3.5 3.5 3.5 
KSTO  mg COD/l 0.3 0.6 0.6 0.7 0.7 
fES - 0.05 0.05 0.05 0.05 0.05 
fEX - 0.15 0.15 0.15 0.15 0.15 
State 
variables 
Unit      
Total 
biomass 
mg VSS/l 900 1050 800 930 900 
XH mg COD/l 900 1125 850 1025 900 
Activity % 71 75 75 77 71 
XSTO mg COD/l 10 12 10 11 10 
SS1 mg COD/l 230 230 200 220 220 
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Figure  4.47: Model simulation of OUR data for Set 8. 
Model simulation results of Set 9.1, Set 9.2 and Set 9.3 were illustrated in Figure 
 4.48, Figure  4.49 and Figure  4.50, respectively. Since these experiments did not 
have PHB samples, model simulation of PHB data could not be done. 
 
Figure  4.48: Model simulation of OUR data for Set 9.1. 
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Figure  4.49: Model simulation of OUR data for Set 9.2. 
 
Figure  4.50: Model simulation of OUR data for Set 9.3. 
Modelling results of modified ASM3 indicated that maximum heterotrophic growth 
rate was found the same with the control experiment on the first day of acclimation, 
and increased from 3.5 to 5 d-1 on the fifteenth day of acclimation. According to the 
simulation results, half saturation constant for readily biodegradable substrate was 
the same for all acetate including chronic experiments. Furthermore, state variables 
including active biomass fractions and the set of model parameters for the twentieth 
day experiment were derived from three interrelated OUR experiments conducted 
on the synthetic substrate (acetate), the SMX and the synthetic substrate/SMX 
mixture so that each model calibration step yielded its own values. As a result, a 
new microbial group capable of metabolizing the antibiotic (XHA), a half saturation 
constant for antibiotic (KSA) and a maximum growth rate of antibiotic degrading 
0
10
20
30
40
50
60
70
80
90
0.00 0.03 0.06 0.09 0.12 0.15
O
U
R
 (m
g 
O
2/
l.h
)
Time (day)
OUR_data OUR_model_total
0
1
2
3
4
5
6
0.00 0.03 0.06 0.09 0.12 0.15
O
U
R
 (m
g 
O
2/
l.h
)
Time (day)
OUR_data OUR_model_total
70 
heterotrophs (μHA) were estimated in the model simulation. Both KSA and μHA 
decreased with respect to KS and μH. Maximum storage rate also decreased from 
5.7 to 3 d-1 on the first day of acclimation. On the other hand, half saturation 
constant for storage increased on the first day of acclimation when compared to the 
value in the control experiment. It was observed that the storage process 
disappeared with the acclimation of activated sludge to SMX. For this reason, µSTO, 
kSTO, KSTO and YSTO were not estimated in both the fifteenth and the twentieth day 
experiments. The model simulation results based on modified ASM3 of Set 3, Set 
8, Set 9.1, Set 9.2 and Set 9.3 were given in Table  4.3. 
Table  4.3 : Results of model calibration for the chronic SMX experiments. 
Assumptions: YH = 0.66 g COD/g COD and YSTO = 0.8 g COD/g COD [52,53]. 
Model 
Parameters Unit Control 
1st day 
(mix) 
15th day 
(mix) 
20th day 
(mix) 
20th day 
(antibiotic) 
20th day 
(acetate) 
μH  3.5 3.5 5 5 - 5 
KS mg COD/l 6 6 6 6 - 6 
μHA 1/day - - - 1 1 - 
KSA mg COD/l - - - 3 3 - 
bH   1/day 0.2 0.45 0.28 0.1 0.1 0.1 
kSTO 1/day 5.7 3 - - - - 
µSTO 1/day 3.5 3.5 - - - - 
KSTO  mg COD/l 0.3 0.6 - - - - 
fES - 0.05 0.05 0.05 0.05 0.05 0.05 
fEX - 0.15 0.15 0.15 0.15 0.15 0.15 
State 
Variables 
Unit       
Total 
biomass mg VSS/l 900 800 820 820 820 820 
XH mg COD/l 900 850 700 900 - 750 
XHA mg COD/l - - - - 150 - 
Activity % 71 75 60 77 13 64 
XSTO mg COD/l 10 10 - - - - 
SS1 mg COD/l 230 200 200 40 - 40 
SSA mg COD/l - 70 70 70 70 - 
Removal 
Efficiency 
Unit       
SS1removed 
for Acetate  
% 93 80 64 83 - 83 
SSAremoved 
for  Antibiotic 
% - - 20 71 71 - 
71 
5 CONCLUSIONS AND RECOMMENDATIONS 
Sulfamethoxazole is one of the extensively used antibiotic compounds which is 
present in high concentrations in both domestic and municipal wastewaters. 
Although sulfonamides are reported as stable against hydrolysis process, 
biodegradability test indicate that SMX is ultimately biodegradable. 
Respirometric experiments displayed a significant information about the inhibitory 
impact of SMX, and it was followed by acclimation of activated sludge to this 
compound. The only acetate fed reactor operated with an efficiency of 90-93% COD 
removal. The removal of the antibiotic compound was not observed on the tenth day 
of acclimation. Acclimation of activated sludge to SMX was observed on the 
fifteenth day of acclimation period resulting in 20% of SMX removal. On the 
twentieth day of acclimation, complete removal was achieved.  
Model simulation estimations proved the dependence of kinetic parameters to 
physiological state of microbial cultures and feeding pattern of substrates. In the 
acute experiments, SMX caused decrease in maximum storage rate; however, 
endogenous decay rate increased. In the chronic experiments, as biomass was 
acclimating the SMX, the storage process disappeared. On the other hand, higher 
maximum growth rate and lower endogenous decay rate were observed.  
As a consequence, SMX has an inhibitory impact on acetate degradation which cause 
decrease on acetate degradation rate. Acclimation to SMX is possible in the presence 
of available substrate, acetate which may be a result of cometabolic degradation. 
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